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This PhD thesis reports the published work done in the laboratories of baselick GmbH and the Ludwig 
Maximilians Universität (LMU). baseclick GmbH was founded by Prof. Dr. Thomas Carell (LMU) in 
collaboration with the chemical company BASF in 2008. Main focus of baseclick is the usage of click chemistry 
for modification of nucleic acids. In the described research work click chemistry is applied to oligonucleotides 
and in particular to DNA nanostructures, to mRNA to be then used in drug development and to produce 
highly labeled probes for fluorescent in situ hybridization. 
Continuing the previous work done at baseclick1, at first click chemistry was applied on DNA nanostructures. 
In this field DNA, is not used as a carrier of genetic information but as material for the production of structures 
with different size, geometry and shape2–8. The main concept behind the technology is based on Watson and 
Crick base pairing interactions, which bring portions of a ssDNA to hybridize with a complementary sequence, 
usually of another ssDNA strand, to form a rigid dsDNA helix. This is used in the rational design of the 
sequences to form complex structures with nanometric precision9,10. 
DNA nanostructures and click chemistry were used to find an alternative to the current state of the art 
methods for gene synthesis in vitro. To date enzymatic synthesis of long DNA fragment is the method of 
choice since solid phase synthesis is not suitable for very long sequences11,12. Enzymatic synthesis approaches 
are based on the activity of either DNA polymerases or DNA ligases reactions13,14, but those methods suffer 
from some limitations: e.g. in the case of ligases the final gene is assembled by overlapping of strands then 
ligated to form a longer fragment, but it starts to be insufficient when a big number of strands need to be 
ligated together. With DNA polymerases the final product is formed by different cycles of the enzyme in a 
multiple step assembly, with the limitation due to the mispriming and formation of secondary structures 
which then lead to errors. 
Therefore in here, in collaboration with the group of Prof. Dr. Tom Brown from University of Oxford, a method 
was developed where, with the help of the DNA origami technique, ligase activity is replaced by chemical 
ligation, in this case click chemistry. 14 oligonucleotides were designed and synthesized with a 5’-terminal 
azide and 3’-terminal alkyne. The oligos where then preorganized in a DNA nanostructure to bring the alkyne 
and azide in close proximity and, most importantly, in a selective order. In this way after the click reaction 
occurs, the full length of the defined sequence is established, with a bio-compatible triazole linkage replacing 
the phosphate bond at the point of the oligo connections. 
In a second project click chemistry was used to stabilize a DNA nanostructure, in this case composed of 24 
different interlocked oligonucleotides15, and at the same time achieve selective labeling with biotin 
molecules in a one pot reaction. This work was done in collaboration with the group of Prof. Dr. Silvia Biocca 
of University of Rome Tor Vergata. DNA nanostructures thanks to their properties such as bio-compatibility, 




nanocontainer, cellular biosensor and in vivo imaging16–19. Anyhow, crucial for these applications is the 
understanding of how different DNA nanostructure enter the mammalian cells3. For this reason, in this work 
five different topological configurations and functionalizations, with size varying from 8 to 80 nm and shape 
from tetrahedral, octahedral, cylindrical, square box and rectangular, have been investigated for their ability 
to interact with the scavenger receptor LOX-1, which overexpression has been associated with tumor 
development in many cancer cells. 
Inspired by the big success that mRNA therapy20 has in the last decade, methods to enable modification of 
very long RNA oligonucleotides, such as mRNA, were established using click chemistry. In vitro transcribed 
(IVT) mRNA, consisting in mRNA produced by RNA polymerases from a DNA template, is nowadays 
considered to be a valid candidate for a novel class of drugs. It was already demonstrated to be efficient in 
several diseases including: vaccination, protein replacement and cancer therapy21–25. Indeed nowadays 
mRNA is playing a central role in vaccination programs against SARS-Cov-2 pandemic. The main idea behind 
the mRNA therapy is to provide IVT mRNA to the patients to help them developing their own cure. For 
example in vaccination, mRNA coding for a specific viral antigen is used to produce an immune response 
leading to the immunogenicity. 
Besides stability issues deriving from using RNA molecule as drugs, another problem arises from the cellular 
delivery of such molecules26–28. Indeed, delivery to a specific target is still an unsolved problem. To date the 
mRNA is delivered to patients using lipid nanoparticle (LNPs) to act as carrier and at the same time as a barrier 
from the extracellular environment29–31. Recent studies demonstrate however that the usage of LNP is not 
the ideal method to deliver mRNA. It has been proven to be less efficient in vivo than what was observed in 
vitro32. Especially in living organisms the main destination is the liver, which is often not the final target for 
the therapy. Also driven by the recent FDA approval of the first siRNA drug (GIVLAARITM), where the siRNA 
has been chemically modified using N-acetylgalactosamine molecules (GalNac) to enable efficient targeted 
delivery33, it is described here a chemoenzymatic approach based on the incorporation of modified 
nucleotides bearing an alkyne or azide moiety (such as 5-ethynyl-UTP or 3’-azido-dd-ATP), that can then be 
labelled post-transcriptionally, using click chemistry. This method allows for example the incorporation of 
specific modifications inside the mRNA that would not be accepted by the RNA polymerases, e.g. targeting-
molecules for specific delivery, or fluorescent dyes for tracking, thus potentially improving the biochemical 
properties of the mRNA.  
Click chemistry was also used to improve the current methods for the preparation of probes used in 
fluorescent in situ hybridization (FISH). FISH is a cytogenetic analysis that allows the detection and the spatial 
localization of specific nucleotide sequences34–38 in tissues or cells. The fluorescent probes, consisting of 
ssDNA, were designed to hybridize only to those parts of the target DNA/RNA with a high degree of 
complementarity. Then by utilizing fluorescent microscopy it was possible to localize where the fluorescent 




fusion, aneuploidy, loss of chromosomal regions, detection of oncogenes and diagnosis of viral infections and 
to date it can also detect other targets such RNA (mRNA) in cells and tissue samples38,39. 
The probes can be prepared in various ways, such as nick translation, random priming, PCR, end labelling or 
NHS-ester chemistry. Most of the probes, especially for RNA detection, are composed of ssDNA which are 
approximately 20-25 nt long, conjugated to a fluorophore via coupling of an amino group introduced at the 
3’ end and an activated ester of the fluorophore40. 
Finally a method for preparation of mRNA FISH probes based on click chemistry is described, where each 
probe contains three fluorophore instead of a single one, thus giving an increment of fluorescent yields and 
allowing microscopy analysis without the need of special deconvolution software. Furthermore this allows 
the detection using fluorescent activated cell sorting (FACS) devices. Enabling FACS analysis is of outmost 
importance especially for clinical studies, where up to now the detection of specific mRNA or chromosomes 







The deoxyribonucleic acid (DNA) is the central molecule involved in the storage of genetic information used 
in the growth, development, functioning and reproduction in the majority of living organisms including many 
viruses41. The structure of the DNA was first solved by J.D. Watson and F. H. C. Crick in 1953 helped by the X-
ray diffraction analysis done by M. Wilkins and R. Franklin42. It is composed of repetitive elements called 
nucleotides. Each nucleotide is a unit formed by a phosphate residue, a pentose sugar (the 2-deoxyribose) 
and a planar aromatic heterocyclic base. The DNA is composed of four bases divided as monocyclic pyridines: 
Cytosine (C) and thymine (T), and bicyclic purines: adenine (A) and guanine (G). The nucleotides are linked 
together by a covalent bond, the phosphodiester bond, between the sugar of one nucleotide to the 
phosphate of the next, forming the so called polynucleotides43. In a single strand DNA filament (ssDNA) the 
hydroxyl group at the C3’ is called 3’-end, and the phosphate group at the C5’ is called 5’-end, thus giving 
orientation to the DNA strand (5’→3’). In a double stranded DNA filament (dsDNA) the two strands of the 
DNA run in opposite orientation. The bases of the opposite strands are bound together via hydrogen bonds 
according to the base pairing rules where thymine forms two hydrogen bonds with adenine and guanine 
forms three hydrogen bonds with cytosine, as shown in Figure 1. This is giving a stabilizing effect on the 
double helix, thus meaning that increasing the G and C content increases the stabilizing effect. As the 
hydrogen bond is not a covalent bond they can be relatively easy broken and re-joined, an important aspect 
that allows, alongside with some biological activities such as replication, also other applications, e.g. 
fluorescent in situ hybridization (FISH) and DNA origami10,38. 
 






















































Hydrogen bonds are not the only stabilizing effect on dsDNA, another stabilizing effect is due to the so called 
base stacking between adjacent bases41. This as well is a noncovalent interaction which gives a major 
contribution to duplex stability, as it is more prevalent in dsDNA than ssDNA. Base stacking depends on the 
aromaticity of the bases and is a hydrophobic and electrostatic force. Like for the hydrogen bond, different 
sequences can influence the degree of stabilization, some combinations give a more stable interaction than 
others. The salt concentration can influence the base stacking effect as well, high salt concentration, e.g. 
MgCl2, can mask the destabilizing effect of the repulsive negative charge on the phosphodiester bonds. 
DNA is known in three different conformations, A-DNA, B-DNA and Z-DNA, depending among others on 
hydration levels, DNA sequence, amount of supercoiling and chemical modified bases. However the most 
common conformation in cells, and used in the projects described below, is the B-DNA44. In this conformation 
the helix is right handed with 10.5 bases per turn of helix, with a distance between adjacent base of 0.34 nm 
and a helical diameter of 2 nm. The knowledge of the structural properties of DNA is of fundamental 
importance in applications such as DNA nanotechnology. 
2.2. DNA synthesis  
Artificial DNA synthesis represents one of the most important advances in molecular biology. The deep 
understanding of the chemical structure and its replication mechanism allowed scientists to develop different 
methods to synthetized DNA in vitro. 
One of the most important strategy is represented by the PCR, developed by K.Mullis45 in 1985. With the 
discovery of thermostable DNA polymerases, it was possible to amplify fragments of DNA exponentially 
during different thermal cycles, generating a high copy number of the original DNA used as template. 
Another important approach is represented by chemical synthesis of short ssDNA fragments. By the usage of 
phosphoramidite chemistry on solid-phase synthesis it is nowadays possible to produce high quality DNA 
oligonucleotide with defined sequences of up to 100-120 nt46. The solid supports are insoluble materials 
where the oligonucleotide is coupled during synthesis. Different types of solid support have been tested and 
so far, controlled pore glass (CPG) and polystyrene turned out to be the most used ones. The synthesis is 
based on the usage of nucleoside 3’-(2-cyanoethyl-N,N-diisopropylphosphoramidite), phosphoramidites as 
building blocks, added one by one per synthetic cycle in a sequence specific manner, from 3’ to 5’ orientation. 
The phosphoramidite synthesis cycle consists of a series of steps summarized in Figure 2. Using a solid 
support, with the first nucleoside already on it, the cycle starts with a detritylation reaction in which the 5’-
DMTr protecting group (4,4′-dimethoxytrityl) on the first nucleoside is removed. Following detritylation, the 
nucleoside is ready to react with the next base, after activation with tetrazole (or a derivate). The activated 
phosphoramidite then reacts with the 5’-hydroxyl group of the nucleoside bound to the support, generating 
a phosphite triester linkage. Even assuming more than 99% yield during the coupling step, there will be a few 




to prevent such unreacted groups to react with the incoming phosphoramidite. At this point the unstable 
trivalent phosphite triester is oxidated to the corresponding pentavalent phosphotriester, Figure 2. The cycle 
is repeated until the desired sequence of the oligonucleotide is complete, then the oligonucleotide is 
removed from the solid support by ammonium hydroxide treatment. 
 
Figure 2: Phosphoramidite synthesis cycle for oligonucleotide synthesis. 
2.3. RNA 
Some organisms, e.g. retrovirus and flavivirus, use ribonucleic acid (RNA) instead of DNA as depositary of the 
genetic information41. In all other organism, RNA acts in different biological roles like coding, regulation and 
expression of genes like for example messenger RNA (mRNA), described below, and the transfer RNA (tRNA) 
that serve as physical link between mRNA and protein sequence during translation. Similar to DNA, RNA is 



















































































to secondary structures. However, some secondary structures, due to the complementary sequence within 
the same strand, are forming regions of dsRNA like for example tRNAs. Another characteristic that differs 
from DNA is the sugar forming the sugar-phosphate backbone that in this case consists of a ribose instead of 
a deoxyribose. The presence of the hydroxyl group in 2’ position makes the RNA less stable, enhancing the 
hydrolysis of the adjacent phosphodiester bond. In RNA the complementary base to adenine is uracil (U) 
instead thymine, Figure 3, forming always two hydrogen bonds. 
 
Figure 3: In RNA thymidine is replaced by uracil, forming anyway always 2 hydrogen bonds in a double strand. 
2.3.1. mRNA 
mRNA is the molecule involved in the transfer of the genetic information from DNA to ribosomes, the site in 
the cell where proteins are synthetized in a process called translation41. Eukaryotic mRNA is composed of 
different regions: A 5’ cap (or m7G cap), a 5’ untranslated region (5’-UTR), an open reading frame (ORF) of 
the gene, a 3’ untranslated region (3’-UTR) and a poly adenine tail47,48. The 5’ cap consists of a 7-
methylguanosine residue linked through a 5’-5’ triphosphate bond before the first transcribed nucleotide. 
The presence of the 5’ cap enhances the stability of the mRNA itself and is important for its recognition by 
the ribosome complex for the start of translation. UTRs are sequences not translated, located before the 
starting codon (5’-UTR) and after the stop codon (3’-UTR), those regions are often folded into secondary 
structures and have been assigned to different functions including stability, localization, ribosome binding 
and translation efficiency by interaction with different proteins. The poly(A) tail is a long repetition of adenine 
nucleotides (often more than 100 nt) added to the 3’ end. It promotes the export from the nucleus and 
enhance the protection from exonuclease degradation. Furthermore it was observed that poly(A) binding 
protein (PABP) can interact with the protein complex at the 5’ cap and form a loop capable to speed up and 
improve the protein production by the ribosomes41. In the last decade, mRNA has attracted attention as a 
valid candidate for a new class of therapeutics, such as vaccination, cancer immunotherapy and protein 
replacement20,49–51. Therefore part of this thesis, chapter 5, describes methods for the modification of such 


















2.4. Click Chemistry 
The term click chemistry, introduced for the first time by Finn and Sharpless in 200152, integrates a series of 
chemical reactions which have common criteria. The so called “click” reactions should be modular, wide in 
scope, resulting in very high yields, stereospecific and produce only non-toxic byproducts that can be easily 
removed from the solution via non-chromatographic methods. In addition, the reactions could be conducted 
in aqueous solution and in the presence of oxygen. Typically, the products of a click reaction require simple 
isolation methods and they are stable under physiological conditions. 
The Cu(I)-catalyzed alkyne/azide cycloaddition (CuAAC) is the most representative and widely used click 
reaction53. The alkyne-azide cycloaddition was originally studied by Huisgen in the 1960s at the university of 
Munich (LMU), where an azide and an alkyne react at high temperature (about 100°C) and with long reactions 
times, generating a mixture of 1,4 and 1,5 regioisomers, thus limiting the usage of the reaction for practical 
applications, Figure 4. 
 
Figure 4. Huisgen cycloaddition.  
2.4.1. Cu-Catalyzed Azide Alkyne Cycloaddition  
In 2002, two different research groups independently improved the regioselectivity and the kinetic of the 
Huisgen reaction, discovering that Cu(I) catalysis leads to only one regioisomer, the 1,4-triazole. Furthermore 
the reaction rate is increased, can be carried at ambient conditions and can tolerate a broad range of 
functional groups54,55. Despite the large use of the CuAAC, the mechanism remained difficult to establish 
because of the multiple equilibria between different reactive intermediates occurring during the reaction. 
While the classical Huisgen 1,3-dipolar cycloaddition is a one-step process, the CuAAC is considered to be a 
step-wise process involving copper within the intermediates. At the first step, there is the formation of Cu(I)-
alkyne complex. This complex lower the pKa of the alkyne which helps the deprotonation and results in 
copper acetylide coordinating with the alkyne. In the next step, the azide binds to the copper forming an 
unconventional Cu(III) metallocycle. This intermediate undergoes then ring contraction to give a copper 






























formation of active Cu(I) species can be generated by Cu(I) or Cu(II) salts by using sodium ascorbate as the 
reducing agent. 
 
Figure 5. Proposal mechanism for the copper-catalyzed azide-alkyne cycloaddition (CuAAC). 
An important finding that contributed to the wide usage of the CuAAC, in particular for biological 
applications, is that by protecting the Cu(I) species from oxidation with nitrogen-based ligands, the reaction 
can be further accelerated, increasing the reaction rate up to 10.000 fold. Wu et al. introduce the tis 
(triazolylmethyl) amine (BTTES)57, that coordinates copper during the reaction, leading to increasing the 
reaction rates in living systems without apparent toxicity. Other examples of ligands are THPTA: Tris((1-
hydroxy-propyl-1H-1,2,3-triazol-4-yl)methyl)amine, TBTA: Tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine, 
BTTAA: 2-(4-((bis((1-(tert-butyl)-1H-1,2,3-triazol-4-yl)methyl)amino)methyl)-1H-1,2,3-triazol-1-yl)acetic 
acid58. 
2.4.2. Strain Promoted Azide Alkyne Cyclo Addition  
In this variant of the classical CuAAC, without the necessity of any catalyst, a stable triazole product is formed 






















































name of strain-promoted azide-alkyne cycloaddition (SPAAC). It is a powerful and versatile chemical reaction 
with broad academic and commercial applications59,60. 
The stability of a cycloalkyne is directly correlated with the C-C C-C bond angle, which, in a ring form cannot 
have the ideal 180°C angle for the sp2-hybridized carbon. An explanation for the spontaneous reaction of the 
cycloalkyne with the azide lies in the favorable enthalpic release of the ring strain, changing from a strained 
ring to a fused ring system with more favorable angle for the sp2-hybridized carbon of the resulting triazole. 
The usage of the CuAAC can be compromised in the context of biological and especially in vivo applications, 
due to the toxicity of the copper(I) species, for this reason selective chemical reactions such SPAAC, that does 
not require the Cu catalysis and are orthogonal to the diverse functionality of biological systems have become 
important in the field of chemical biology60,61. 
 
Figure 6: Strain promoted azide alkyne cycloaddition (SPAAC). 
2.4.3. Click chemistry on nucleic acids  
In the recent years, click chemistry has become a powerful tool in many applications, including drug 
discovery, cell biology, peptide chemistry and in particular oligonucleotide chemistry 62–65. The usage of click 
chemistry on nucleic acid was thoroughly examined by Prof. Dr. Thomas Carell at the LMU Munich, which has 
led to the founding of the spin-off company baseclick GmbH. The studies from the Carell group66,67 
established the CuAAC as highly efficient method for post synthetic labelling of nucleic acid. Generally, alkyne 
groups were introduced in the 5-position of the pyrimidines nucleobase and position 7 of purines. Alkyne 
phosphoramidites were synthetized and used in solid phase synthesis of DNA oligonucleotide. Two alkyne 
linker were studied in combination with different labels varying in density such as coumarin, fluorescein and 
sugar azide. Furthermore, the modified deoxynucleoside triphosphate, uridine and cytosine analog, were 
accepted as substrates in a PCR67. In this study more than 800 alkyne groups were introduced in a 2000 bp 
PCR product, showing quantitative labeling rate with at least 95% reacted with the azido sugar.  
Nowadays click chemistry is an extraordinary powerful and versatile reaction used routinely in the field of 

















3. Aim of the thesis  
I joined the baseclick team thanks to a European grant (Horizon 2020 Innovative Training Network, ITN) with 
the name of ClickGene. As suggested by the name the project was unified by the usage of click chemistry 
(Click) on nucleic acid (Gene), therefore the aim was to apply click chemistry on oligonucleotides. Herein it is 
described as a powerful tool that allows the conjugation of two (bio)molecules in different applications: e.g. 
alternative methods for gene synthesis in vitro, labeling and stabilization of DNA nanostructures, IVT mRNA 
modification, and mRNA detection via FISH. 
 
Considering that part of this thesis work was carried out in a company we also aimed to the commercialization 
of products, endeed it has to be noted that part of the work resulted in commercially available products, such 






4. Gene Assembly via One-Pot chemical Ligation of DNA Promoted by DNA 
Nanostructure 
4.1. Prologue 
A high quality solid phase synthesis of nucleic acids depends on different factors: on the sequence length, 
nucleotide composition and purification system46. Therefore, syntheses below 100 nucleotides are preferred 
to achieve reliable oligonucleotides in the required amount using solid phase methods. In order to overcome 
these limitations and to achieve a production method for very long oligonucleotides or gene fragments, 
various approaches based on joining multiple oligonucleotides have been developed. Currently two main 
strategies are considered for gene synthesis from oligonucleotides in vitro68–70, both based on enzymatic 
methods: the first is based on DNA ligase (Figure 7) and the second on DNA polymerase (Figure 8). In the 
ligation methods, which represent the earliest example of synthetic gene synthesis, the double-stranded DNA 
is formed by complementary overlapping strands, subsequently joined by the ligase to produce larger 
fragments. The ligase requires the 5’ ends to be phosphorylated, so the set of oligonucleotides used must be 
phosphorylated before. An advancement of this technology was the discovery of thermostable DNA ligases 
and the development of ligase chain reaction, very similar to the polymerase chain reaction, where the gene 
fragments are produced by several cycles of ligation13. This method has become very common and largely 
used, however once the ligation is finished, the gene needs to be amplified by standard PCR. 
 
Figure 7. Ligase based methods. a) The ligase is used to ligate-assemble overlapping oligonucleotides into a single 
strand. b) A thermostable ligase is used in a stepwise synthesis where the growing DNA sequence is anchored to a 












In the second method, based on DNA polymerase cycling assembly (PCA), the desire gene is produced as 
multiple step assembly. A solution containing all required oligonucleotides and a DNA polymerase, is 
subjected to a similar cycling as in the PCR. During each cycle, pairs of oligos anneal and extend, forming a 
duplex including the sequence between the ends of the two olignucleotides overlapping. Bigger duplex will 
be formed and after several cycles a full-length fragment will exist (most often as a set PCR products with 
various lengths). As the ligation technology, the PCA is based on a series of overlapping oligonucleotides, 
however there is no need that the oligos form the entire double-stranded product but there can be spaces 
between oligos on the same strand, since during the first PCR assembly reaction, overlapping oligos will 
anneal and extend using each other as template to form longer DNA fragments. Same as the other method, 
the PCA does not result in exponential growth of the DNA, so a final PCR reaction is needed to amplify the 
full lenght product14. Although these methods – along with all documented variations - give access to a large 
variety of DNA fragments, there are some limitations due to mispriming during the assembly, formation of 
secondary structures or to repetitive sequences that can hinder the polymerase activity. Moreover, in the 
fast evolving genomic, epigenomic and DNA-nanotechnology fields, the demand for functional gene 
fragments are not yet matched and alternative approaches are strongly needed. Thus, in our work we 
propose an alternative to the enzymatic methods for the production of gene fragments, using chemical 
ligation. 
 
Figure 8. Top left, A series of overlapping oligonucleotides amplify one another to produce a mixture of product, 
eventually including the full-length gene. Then this mixture is used for a final PCR reaction using primers to 
selectively amplify only the full length product. Bottom left, in this case the product is produced by at first 
assembling ca 500bp blocks of overlapping oligonucleotides. Higher concentration of the flanking primers 
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(expressed here by the thickness of the arrows) facilitate the assembly of the block. Then the blocks are assembled 
into a full-length gene with a final PCR. Top right, a gradient concentration of the primers resulting in selective 
pressure for amplification of eventually the full-length gene. Bottom right, this method is based on the formation 
of mini-fragments by briefly extending primers pair. These pairs then are used to build larger fragments, then 





4.2. Abstract of the publication “ Gene Assembly via One-Pot Chemical Ligation of DNA 
Promoted by DNA nanostructure” 
Current gene synthesis methods are driven by enzymatic reactions. Here we report the one-pot synthesis of 
a chemically-ligated gene from 14 oligonucleotides. The chemical ligation benefits from the highly efficient 
click chemistry approach templated by DNA nanostructures, and produces modified DNA that is compatible 
with polymerase enzymes. 
4.3. Author contribution 
The author planned the experiments and carried out the folding reactions, the chemical and enzymatic 
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Gene assembly via one-pot chemical ligation of
DNA promoted by DNA nanostructures†
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Current gene synthesis methods are driven by enzymatic reactions.
Here we report the one-pot synthesis of a chemically-ligated gene
from 14 oligonucleotides. The chemical ligation benefits from the
highly efficient click chemistry approach templated by DNA nano-
structures, and produces modified DNA that is compatible with
polymerase enzymes.
The DNA nanotechnology and synthetic biology fields rely on
synthetic oligonucleotides that are assembled to form nano-
structures and artificial genetic systems. Synthesis of high
quality oligonucleotides by solid phase synthesis1 depends among
other factors on the sequence length, nucleotide composition and
the purification system used. Yields exceeding 99% are not rare for
each coupling step, although even the most efficient synthesis
setup cannot reach 100% coupling efficiency. Therefore, the over-
all percentage yield of oligonucleotides strongly depends on their
length. For instance, the synthesis of a 200-mer, where each cycle
has an efficiency of incorporation of 99%, yields 13% of full-length
product without taking in account further purification steps.
Therefore, synthesis of oligonucleotides that are shorter than
100 nts is preferred in order to achieve reliable yields.
Furthermore, the acidic reagents used for the de-tritylation
step can lead to the formation of abasic sites and cleavage of
the biopolymer, further decreasing the yield of full-length
oligonucleotides.2 Various approaches based on joining multiple
short oligonucleotides have been developed to overcome these
limitations with the goal of assembling long synthetic DNA
strands (genes and gene fragments).3–5 Currently two main
strategies are used, both based on procedures that involve the
use of enzymes. The first utilises DNA ligase whereas the second
relies on the activity of DNA polymerases.3,4 In the ligation
method, which represents the earliest example of synthetic gene
synthesis, the double-stranded DNA is assembled from comple-
mentary overlapping strands subsequently joined by the ligase
to produce longer fragments, which requires 50-phosphorylated
oligonucleotides. This method becomes inefficient when large
numbers of oligonucleotides are ligated.3 In the second method,
called DNA polymerase cycling assembly (PCA), which is based
on the activity of DNA polymerase enzymes, the desired gene
fragment is produced in a multiple step assembly.4 Although
these methods give access to a large variety of DNA fragments,
there are some limitations due to mispriming, formation of
secondary structures, and mistakes that occur when assembling
repetitive sequences that hinder the polymerase activity. Therefore,
in the rapidly evolving genomic, epigenomic and DNA nano-
technology fields the demand for functional gene fragments are not
yet fully met, and alternative approaches are urgently needed.
To address this issue non-enzymatic ligation methods have
been explored. Brown and collaborators reported a biocompatible
chemical linkage that is read by polymerases both in vitro and
in vivo in E. coli and human cells.5–9 The authors previously proved
the efficiency of copper-mediated azide/alkyne cycloaddition
(CuAAC),10,11 the classic click chemistry reaction,12 as a ligation
method for oligonucleotides. A major advantage of this technique
is the high reaction efficiency in aqueous buffer, which makes
CuAAC a suitable reaction for conjugation of biomolecules.13
Following this work, recently, Kukwikila et al. demonstrated
enzyme-free, click-mediated gene assembly starting from 10
functionalized oligonucleotides that overlap to create a small
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335 bp gene. The assembled gene is functional both in vitro and
in vivo, confirming the biocompatibility of the triazole linkage.14
The assembly approach used by Kukwikila et al. is based on
splint oligonucleotides, but it is known that when increasing the
number of strands to create a long gene, the complexity of the
assembly increases significantly, often leading to failure in
the synthesis of full-length sequences.15 An alternative method
to chemically ligate DNA strands is based on formation of
phosphoramidate linkages. In this case, 30-amino-modified
oligonucleotides react with 50-phosphorylated partner strands
in templated reactions. This method has been recently used for
gene synthesis16 and also to circularize DNA nanostructures.17
The field of DNA nanotechnology has produced a large number
of sophisticated 2D and 3D DNA nanostructures that have been
applied in many research fields. It has been proven that DNA
origami is a robust assembly method where a long single-
stranded DNA scaffold is folded with the help of short DNA
strands called staples.18 DNA origami has been widely used
for organization of bio/nanomaterials at nanoscale precision,
however, the use of DNA origami for gene assembly has not
been reported. One of the great features of this technique is that
the designed structure has the most stable conformation among
all possible.19 Therefore it provides control over position and
stoichiometry of each strand involved in the assembly. In this
manuscript we explore these features and adapt them to gene
synthesis. For this purpose, we tested a derivative of the DNA
origami technique, where the scaffold is fragmented into B60 nt
long strands (gene oligonucleotides, GOs) and it folds with the
help of staple strands.
In this manuscript we describe a one-pot click assembly
procedure inspired by established self-assembly techniques
from the DNA nanotechnology field, affirming that genes can
be obtained by chemical ligation of several short DNA strands.
The work paves the way to the synthesis of long DNA fragments
and genes by combining the geometrical precision achieved
with DNA nanostructures and the highly efficient click chemistry-
mediated ligation. In this work we demonstrate the synthesis of a
762 bp gene encoding the enhanced green fluorescent protein
(EGFP) from 14 functionalized oligonucleotides. The system
employs a DNA nanostructure – a 6-helix bundle (6HB)20 – as
vehicle for assembling single stranded DNA bearing triazole
linkages that are converted into double strands after PCR
amplification. Using this technique, we assembled a 6HB where
all GOs (30 alkyne, 50 azide-modified) are brought in close
proximity, ordered in a predesigned fashion with an equimolar
stoichiometry and ligated through click chemistry. The resulting
product is then amplified by PCR to convert the triazole linkages
in a canonical phosphodiester backbone (Fig. 1). The design was
executed using the caDNAno software package21 using the
following principles: (1) the 762 nt long gene runs through the
nanostructure forming the single-stranded scaffold of a 6HB of
B40 nm in length. (2) The gene scaffold is fragmented into
strands of B60 nt to assure reliable chemical synthesis of the
double functionalized GOs. (3) The staples are designed to allow
the structure to fold in a hierarchical order. The gene was
divided into 14 GOs; 12 internal GOs bearing a 50-terminal
azide-modified thymidine and a 30-terminal alkyne-modified
deoxycytidine and two terminal GOs mono-functionalized as
50-azide and 30-alkyne respectively.
To test the folding of the 6HB nanostructure, unmodified
GOs were initially used. We found that the 6HB presented here
folds in presence of 20 mM MgCl2 with formation of two
species (Fig. 2a). The sample was analyzed by AFM and, as
expected, the species were found to be monomers and dimers
of the designed 6HB, with an average length of 43  4.5 nm for
the monomers and 82  3.4 nm for the dimers (Fig. 2e). The
length of monomers from AFM results agrees with theoretical
calculation (42 nm). Dimer formation is probably due to stacking
interactions between terminal base pairs of two different 6HB.
The fact that only dimers, but not trimers or larger assemblies are
formed, indicates that only one end of the 6HB tends to participate
in base stacking. We speculated, and later confirmed, that the
Fig. 1 Gene assembly process. (a) Chemical ligation mechanism. Coloured
shapes represent the molecule on their left. (b) Gene oligonucleotides (blue,
GOs) – bearing chemical modifications at the 30 and 50-ends – and staples
(colours other than blue) are folded, forming the 6HB construct (c) caDNAno
blueprint: helices are marked with roman numerals. (d) Click chemistry of the
GOs in the 6HB forms a long linear scaffold (in blue). (e) 3D views of the
designed DNA nanostructure with green pentagons to highlight click points
(triazoles). (f) The ligated DNA strand in the nanostructure is used as a
template for PCR amplification forming a product with a canonical
phosphate backbone. In figure c and d, the tips of the small arrows
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presence of the two species does not interfere with the gene
assembly.
We then carried out chemical ligation of the EGFP gene,
folding the 6HB using the 14 modified GOs and the complementary
staples. Ligation through click chemistry – assisted by the close
proximity of the GOs pre-organized in the nanostructure – was
conducted using a protocol from Cassinelli et al.22 The gel
containing magnesium ions (AGE-Mg) in Fig. 2b shows that
the structure retains its conformation after the click reaction. In
contrast, in an AGE without magnesium ions (Fig. 2c), the
structure prior to the click reaction unfolds, whereas the ligated
structure (‘‘click BAS’’ in Fig. 2c) entirely retains its conformation.
Chemically-ligated 6HB constructs were examined by AFM and
they were shown to have a similar length to the 6HB having an
unligated scaffold (42  4.2 nm for the monomer and 78 
3.5 nm for the dimer) (Fig. 2f). However, PAGE analyses in
denaturing conditions of the EGFP gene assembly was not very
informative: many bands formed after the click reaction without
any particular predominance (Fig. S1, ESI†). We speculated that
the band corresponding to the full-length gene might be the
closest to the well of the denaturing gel, but since we observed
that triazole-containing oligonucleotides run slower than their
unmodified counterpart, we could not reliably refer to the ladder
in assessing their size.
The crude chemical ligation mixture was then used as
template for PCR amplification. Primers were designed in order
to amplify only the full length gene. Amplification of the full-length
EGFP gene was successful when both Taq polymerase (low
fidelity) and Baseclick polymerase (high fidelity) were employed
(Fig. 2c). To assess the accuracy of the gene assembly method,
PCR products were cloned and sequenced. In both cases, 5% of
the screened clones resulted in 100% identity with the designed
gene sequence (Tables S1–S3, ESI†). This is an encouraging
result if we consider that one of the polymerase tested in the
PCR step is Taq polymerase, classified as relatively low-fidelity
due to its error-rate of 2.3 105 (vs. 9.5 107 of a high fidelity
polymerase).23 At this point we calculated the error rate of the
polymerase in our gene assembly method to understand if the
system is prone to mutations, or whether the triazole groups
interfere with the correct incorporation of bases during PCR. An
estimation of the error rate of the system was obtained by
comparing our results to published data for the fidelity of Taq
polymerase, which is reported to incorporate 1 error every 700–
1700 bp depending on the source of the mutation data.24 In our
system Taq polymerase incorporated 1 error every 254 bp. This
may indicate that the high concentration of metal ions present
in the crude ligation mixture used as template for PCR may
interfere with the activity of DNA polymerases, this can be
addressed by exchanging the ion rich buffer with water. However,
we cannot exclude that some of these mutations may be produced
during the chemical synthesis of the starting oligonucleotides.
Sequencing results show that mutations are homogeneously
localized along the assembled gene fragment and that the
triazole backbone is correctly replicated as previously shown.5
Finally, the method was compared to splint-assisted ligation
in the absence of a nanoconstruct to prove the utility of the
DNA nanostructure in assembling multiple gene oligonucleotides
in equimolar ratio. The 14 GOs were assembled using 13
complementary splint oligonucleotides and chemically ligated
with the same procedure used for the 6HB nanostructure. The
ligation product was used as template for a PCR reaction where
we employed KOD XL DNA polymerase, which is expected to
efficiently read through the triazole linkage. Fig. 2d shows
the PCR products of the splint-mediated assembly, the 6HB
assembly and a positive control (PCR of the EGFP gene). PCR of
the splint assembly did not produce full-length EGFP gene, but
artifacts of higher and lower molecular weight, while PCR of the
6HB assembly showed a product of the same length as the
control. However, the PCR products obtained using KOD XL
polymerase were not as homogeneous as the ones employing
Taq polymerase or Baseclick polymerase.
In conclusion, we have developed a system for gene fragment
assembly by chemical ligation promoted by a DNA nanostructure,
where gene fragments are part of the scaffold that runs inside the
nanostructure. These are assembled in a predefined fashion, so
that 30-alkyne and 50-azide are in close proximity, forming a 6HB
nanostructure. The use of the nanostructure proved to be an
efficient method to achieve an equimolar ratio of oligonucleotides,
which is otherwise difficult when several oligonucleotides have to be
ligated together. With this technique we were able to assemble 14
gene oligonucleotides to create a 762 nt long DNA strand, that
after PCR is converted into a canonical double-stranded gene,
encoding for EGFP. The method proved to be more efficient
Fig. 2 Assembly experiments. (a) Salt screening test (mM MgCl2): the
structure formed at concentrations above 10 mM. Two species products
(monomer and dimer) were found. (b) The product of the click reaction
with the heterogeneous catalyst contained in the vial ‘‘reactor M’’ (BAS)
runs like the folded sample. (c) The 6HB after click reaction is stable in
absence of Mg ions. The PCR with Taq polymerase shows a product of the
correct length. (d) Comparison between splint assembly without a nano-
structure and assembly in the 6HB. The latter shows a product of the same
length as the positive control (last lane, PCR on the EGFP gene). (e) AFM of
the folded sample: monomers of B43 nm and dimers of B82 nm are
formed. (f) AFM of the ligated sample: monomers of B42 nm and dimers
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than the equivalent ligation performed using splint oligonucleotides
in the absence of the nanostructure. The chemical ligation method
based on the CuAAC reaction is fast and efficient and can be carried
out in a variety of biologically compatible buffers. Interestingly this
gene is twice the size of the only one previously synthesized by
CuAAC-mediated ligation.15 This method should provide a general
route to the synthesis of larger genes as well as long DNA
strands for use in DNA nanotechnology and synthetic biology
for the construction of complex nanostructures and synthetic
organisms. We further envision the use of this technology to
chemically assemble genes decorated with modifications such
as epigenetic bases, fluorophores or haptens, which could have
important applications in the fields of DNA nanotechnology and
synthetic biology.
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Experimental procedures
Design of the 6HB
The design of the 6HB was supported by caDNAno software. After introducing the 
sequence of the scaffold the staples were added automatically by the software and 
then manually modified to achieve a hierarchical folding.
In Supplementary Figure 3 a high-resolution blueprint with gene oligonucleotides and 
staples is shown.
Folding of the 6HB
Electronic Supplementary Material (ESI) for ChemComm.
This journal is © The Royal Society of Chemistry 2018
Samples were made mixing staples and in-house synthetized GOs in ratio 1:1 to a 
final concentration of 500 nM/each oligo in 1X TE buffer with 20 mM MgCl2. The 
sample was folded in a thermocycler using the following program: from 95 ºC to 80 
ºC with a ramp of 1º C/min, from 80 ºC to 40 ºC with a ramp of 0.03ºC/min, from 40 
ºC to 23 ºC with a ramp of 0.1 ºC/min and final hold at 8 ºC.
Click reactions on the 6HB
-  Click reaction (CuAAC) using an heterogeneous catalyst
A volume of 15 µl of THPTA 0.1 M was added to the “reactor M”, a vial containing the 
heterogeneous catalyst (baseclick), then 20 µl of folding reaction was added to the 
“reactor”. The sample was incubated at 32ºC with gentle shaking (200 rpm) for 5h.
- Click reaction (CuAAC) using CuSO4 
The Baseclick EdU kit (reaction buffer, catalyst solution and reducing agent/buffer 
additive) was used for the experiments with CuSO4 as source of Cu(I). The 
indications of the producer were used for the ligation assay using the click reaction. 
In this case, 40 µl of folding reaction were used in the assays.
- Click reaction (CuAAC) using CuBr 
For the experiments with CuBr as source of Cu(I): 1 mg of CuBr was weighted under 
inert atmosphere and dissolved in 70 µl of “click solution”. A total of 5 mg of the 
ligand TBTA were dissolved in 94 µl click solution and the two solutions were 
combined in ratio 1:2 (TBTA:CuBr). A volume of 20 µl of the mix were mixed with 4 µl 
of the folding reaction and incubated at 32ºC with gentle shaking.
AGE/AGE-Mg
AGE/AGE-Mg were prepared dissolving agarose (Ultra-pure, Thermo Scientific) to 
achieve a 1% gel in 0.5X TBE buffer (and 11 mM MgCl2 final concentration for AGE-
Mg, 1X TAE was used when the bands were extracted from gel). The gel was casted 
and left solidify at RT for 30 min.
PCR reactions
All the PCR reactions were tested using the following primers (Metabion):
FW EGFP 1-14 TATCACTATCGACGGTA
REV EGFP1-14 ACTTACAGCTTTACTTG 
A volume of 1 µl of click reaction was used as template for PCR. The incubation with 
Taq Polymerase (NEB) and KOD XL (Millipore) proceeded as follows: 94 ºC for 3 
min, 80ºC for 30 sec (add polymerase); 94 ºC for 45 sec, 30 ºC for 30 sec, 72 ºC for 
12 min, repeat for 4 times; 94 ºC for 45 sec, 46 ºC for 30 sec, 72 ºC for 72 sec, 
repeat 10 times; 72 ºC for 10 min. Incubation with Baseclick polymerase proceeded 
as follows: 98 ºC for 90 sec; 98 ºC for 10 sec, 58 ºC for 20 sec, 72 ºC for 15 sec, 
repeat 20 times; 72 ºC for 8 min.
Sequencing
PCR reactions were cloned into a plasmid using the TOPO PCR cloning kit by 
Thermo Fisher Scientific and following manufacturer instructions. Plasmids from 
clones were extracted with Gene Elute HP Miniprep by Sigma-Aldrich and sent to 
sequencing to GATC Biotech.
AFM imaging
A volume of 2 µl sample was deposited on freshly cleaved mica and incubated for 1 
min. Subsequently, 400 μl of imaging buffer (1× TAE-Mg2+ containing 5 mM NiCl2, 
1× TAE-Mg-Ni) were added into the cell. Nanostructures were visualized by tapping 
mode AFM (Agilent AFM series 5100) using silicon nitride cantilevers (Olympus). All 
recorded AFM images were processed and analyzed by Gwyddion software.
Supplementary Figures
Supplementary Figure 1. Denaturing PAGE of the 6HB after folding and after 
ligation with different catalysts. Many bands are formed, but the complete EGFP 
gene is not detectable using PAGE, probably due to the low yield of the long 
sequence. To understand whether a different catalyst could give higher yields in the 
formation of the “ligated gene”, CuAAC reaction using CuSO4 as source of Cu(I) was 
tested. The sample appears like a light smear, probably because the reagent 
interferes with either the electrophoresis or the staining of DNA. CuBr was also 
tested as source of Cu(I), but the results are similar to the ones obtained with the 
heterogeneous catalyst.
Supplementary Figure 2. Gene assembly in the 6HB of (a, b, c) 4, (d, e) 3 and 5 
modified gene oligonucleotides. (a) Folding and click reaction on the 6HB using 4 
modified gene oligonucleotides. The nanostructure forms using both a set of 
unmodified gene oligonucleotides or a set containing only 4 modified gene 
oligonucleotides. (b) Only the ligated structure partially retains its conformation in an 
AGE without Mg2+ ions. (c) Denaturing PAGE of the folded and ligated structures with 
4 modified gene oligonucleotides or fully unmodified. Only after the click reaction is a 
band of high molecular weight corresponding to 4 ligated fragments visible (first 
lane). (d) Folding and click reaction on the 6HB using 3 and 5 modified gene 
oligonucleotides. (e) Denaturing PAGE of the ligation product in (d). Bands 
corresponding to 3 and 5 ligated gene oligonucleotides are visible on gel.
Supplementary Figure 3. Blueprint of the 6HB used in this manuscript. GOs are in 
blue, staples are represented in other colors. Arrow heads indicate the 3’end. 
Numbers on the 5’-end of the blue strands indicate the name of the GOs (i.e. 1 = 
EGFP1, 12 = EGFP12).
Supplementary Text
Sequencing result analysis of PCR products using Taq polymerase (medium-
low fidelity)
Table S1: number of mutations (divided into substitutions, deletions and insertions) 




A02 2 (9 bp after click 
point)
1 (13 bp before 
click point)
1
B01 2 (12 bp, 9bp 
before click point)
1 (9 bp before click 
point)
1 (8 bp before click 
point)
D02 3 (16 bp before 
click point)
0 0
D03 0 0 0
H03 2 (13 bp before 
click point)
0 0
H04 1 0 0
H06 0 0 0
48 clones were sent for sequencing.
38 clones produced sequencing result.
33 clones had the PCR products as insert.
7 clones have a 762 bp insert.
2 clones (D03 and H06) have 100% identity with the designed sequence.
~5% of the clones that produced sequencing results showed 100% identity with the 
designed sequence.
Sequencing result analysis of PCR products using Baseclick polymerase (high 
fidelity)
Table S2: number of mutations (divided into substitutions, deletions and insertions) 
for each sequenced clone containing ~762 bp insert.
20 clones were sequenced
Clone name Deletions Substitutions Insertions
EGFP_3_1 0 0 0
EGFP_3_2 3 1 0
EGFP_3_3 0 1 0
EGFP_3_4 0 2 + 2 c 1
EGFP_3_5 0 1 0
EGFP_3_6 0 1 0
EGFP_5_1 1 2 0
EGFP_5_2
2 c, 15 c (part of 
GO5)
2 0
EGFP_5_3 1 1 0
EGFP_5_4
60 c (whole GO10)+ 
1
0 0
EGFP_5_5 0 2 0
EGFP_5_6 2 c 1 0
EGFP_5_7 3 0 0
EGFP_8_1 1 + 3 c 0 1
EGFP_8_2 1 0 0
EGFP_8_3 4 1 0
EGFP_8_4 0 1 0
EGFP_8_5 4 1 0
EGFP_8_6 2 2 0
EGFP_8_7 7 0 0
Tot (considering long deletions 
as 1)
37 21 2
(GO10: gene oligonucleotides EGFP10; 2 c: 2 consecutive mutations)
Table S3: Description of mutations close to click points
Clone name
Sequence surrounding CT 















The click region of gene oligonucleotides 9-10 appears to be prone to mutations. We 
speculate that GO10 might not have enough complementary bases at the level of the 
staples (see Supplementary Figure 3). This might explain why gene oligonucleotides 
10 (represented in red box, Fig Sx) is missing in one of the clones sequenced.
Oligonucleotides
All reagents for chemical synthesis were purchased from Sigma-Aldrich. Unmodified 
oligonucleotides were acquired from Metabion International AG, while 3’-alkyne and 


















































































EGFPn modified sequences were synthesized with 3'-alkyne and 5'-azide.








5. Cellular uptake of covalent and non-covalent DNA nanostructures with different 
size and geometry 
5.1. Prologue 
In recent years, DNA has been used as building block for the production of nanostructures with different 
biomedical applications, such as drug delivery and cellular biosensors, which has led to a rapid growth of the 
DNA nanotechnology area6,18,71,72. The need for spatial precision and organization at the nanometer level for 
biomedical applications is an important aspect to consider for the introduction of exogenous particles into 
living systems, and this can potentially be achieved by employing DNA nanostructures. Indeed, they can be 
easily and precisely modified with a variety of different molecules such as receptor ligands for targeting 
purposes3. To date, a plethora of DNA nanostructures based on Watson and Crick base pairing has been 
prepared and studied. Different methods have been developed for the production of the so-called DNA 
nanostructures, Figure 9. The technique of DNA origami was the first one to be developed and demonstrated 
in 2006, with the pioneering work of P. Rothemund6. The method is based on the usage of a very long ssDNA, 
usually from bacterial or viral origin, called “scaffold DNA”, folded by the help of short ssDNA oligos, called 
“staples”, designed to bring different parts of the scaffold together. Thanks to the robustness of the methods, 
it has widely and often been used as main technique for DNA nanotechnology preparation.  
 
Figure 9: Left, schematic representation of the DNA origami technique, a long ssDNA (scaffold) is folded through 
the usage of short ssDNA (staples) in a precise geometrical structure. Right AFM imagine of the DNA nanostructure. 
I.Bald et al. Molecules, 2014, 19, 13803-13823. 
Since then, other methods have been developed as well, such as the so called “tile assembly”73 where shorter 




hybridizes with another ssDNA region of another tile, thus avoiding the usage of the very long ssDNA, Figure 
10.  
 
Figure 10: Different tile assembly method, based on short ssDNA, for the production of DNA nanostructures. M.B.Ra 
et al., Trends in Biochemical Sciences, 2018, 17,1512 
To be considered a viable tool to build biomedically relevant carriers, the material should maintain long term 
stability in various physiological environments as well as represent a suitable shuttle to the target and/or 
subcellular destination, thus DNA nanostructures have already been used as delivery vehicle for different 
molecules, including anticancer drugs. 
Furthermore, signal transduction is an important aspect where DNA nanostructures may have potential 
advantages, due to their intrinsic bio-chemical property to “communicate” with biological systems and 
therefore be an excellent connection for exchange of information. Driven by these findings, we thought to 





5.2. Abstract of the publication “Cellular uptake of covalent and non-covalent DNA 
nanostructures with different size and geometry” 
DNA nanostructures with different size and shape, assembled through either covalent or non covalent bonds, 
namely tetrahedral and octahedral nanocages, rod-shaped chainmails, square box and rectangular DNA 
origami structures, were compared for their stability in serum, cell surface binding, internalization efficiency, 
and intracellular degradation rate. For cell internalization a specific cell system, highly expressing the 
scavenger receptor LOX-1, was used. The results indicate that LOX-1 binds and internalizes a broad family of 
DNA structures of different size that, however, have a different fate and lifetime inside the cells. Covalently-
linked tetrahedra, octahedra or chainmails are intact inside cells for up to 18 hours whilst the same DNA 
nanostructures without covalent bonds along with square box and rectangular origami are rapidly degraded. 
These data suggest that noncovalently linked structures may be useful for a fast drug release whilst the 
covalently-linked structures can be appropriate vehicles for slow releasing molecules. 
5.3. Author contribution 
The author carried out the labeling and characterization of the oligo containing biotin molecule. The synthesis 
of the DNA nanostructure, the so called chainmail, it´s chemical ligation via click chemistry and helped in the 
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Cellular uptake of covalent and non-covalent
DNA nanostructures with different sizes and
geometries†
Sofia Raniolo, a,d Stefano Croce,b Rasmus P. Thomsen,c Anders H. Okholm,‡c
Valeria Unida,d Federico Iacovelli, d Antonio Manetto, e Jørgen Kjems,c
Alessandro Desideri d and Silvia Biocca *a
DNA nanostructures with different sizes and shapes, assembled through either covalent or non-covalent
bonds, namely tetrahedral and octahedral nanocages, rod-shaped chainmails, square box and rectangular
DNA origami structures, were compared for their stability in serum, cell surface binding, internalization
efficiency, and intracellular degradation rate. For cell internalization a specific cell system, highly expres-
sing the scavenger receptor LOX-1 was used. The results indicate that LOX-1 binds and internalizes a
broad family of DNA structures of different sizes that, however, have a different fate and lifetime inside the
cells. Covalently linked tetrahedra, octahedra or chainmails are intact inside cells for up to 18 hours whilst
the same DNA nanostructures without covalent bonds along with square box and rectangular origami are
rapidly degraded. These data suggest that non-covalently linked structures may be useful for fast drug
release whilst the covalently-linked structures could be appropriate vehicles for slow release of
molecules.
Introduction
In recent years, the nanotechnology field has grown quickly
and an impressive variety of materials have been used to build
nanoparticles of different sizes and shapes. In particular, DNA
has been extensively investigated for designing programmable,
self-assembling nanostructures for various biomedical appli-
cations, such as drug delivery, cellular biosensors and in vivo
imaging, due to its intrinsic biocompatible, nontoxic and
stable properties.1,2 Crucial for these applications is the ability
of DNA-based nanostructures (DNS) to enter mammalian cells.
Studies addressing different topological configurations and
functionalization of DNS that may improve selective targeting
and interaction between DNS and cell membranes may offer
insights for their optimization.
For entering into cells, short single- or double-stranded DNA
pieces need cationic transfection reagents that help to overcome
the electrostatic repulsive forces between their phosphate back-
bone and the cell membrane.3 Notably, DNA assembled into
three-dimensional structures, such as nanocages, chainmails
and origami, can enter a wide variety of cell types without the
aid of transfection agents.4–10 Selective targeting can be
achieved through the functionalization of DNS with specific
ligands such as folate, transferrin or aptamers, leading to reco-
gnition of specific receptors and improved entry into specific
cell types.11–17 While the intracellular fate and localization of
DNS is strongly dependent on the receptor mediating their
uptake,18,19 the importance of DNS size and shape in cellular
uptake has been taken into consideration just recently.20,21
The main responsible targets for the internalization of
DNA-based nanostructures into cells are scavenger receptors,
having a broad ligand-binding specificity.20,22–24 These recep-
tors constitute a large family of cell-surface receptors that typi-
cally bind multiple ligands, including a wide variety of poly-
anionic molecules.25 Oligonucleotide-decorated gold nano-
particles, wrapped by a dense monolayer of DNA on their
surface, have been shown to interact with scavenger receptors
of class A (SR-A) and class B (SR-B)22 and, more recently, we
demonstrated that pristine octahedral DNA nanocages specifi-
cally interact with LOX-1, a scavenger receptor of class E
(SR-E1).24 Pristine octahedral nanocages are very efficiently
internalized in vesicular structures, which traffic through lyso-
†Electronic supplementary information (ESI) available. See DOI: 10.1039/
c9nr02006c
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Aarhus N, Denmark.
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cInterdisciplinary Nanoscience Center (iNANO), Aarhus University, Aarhus, Denmark
dDepartment of Biology, University of Rome ‘Tor Vergata’, Via della Ricerca
Scientifica 1, 00133 Roma, Italy
eMetabion, Gesellschaft für angewandte Biotechnologie mbH, 82152 Planegg,
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somes, by a LOX-1-mediated uptake. The amount of interna-
lized cages in LOX-1-expressing cells is 30 times higher than in
cells not expressing this receptor.24
LOX-1 is the major receptor for oxidized low-density lipo-
protein (ox-LDL) in endothelial cells.26 It binds its natural sub-
strate ox-LDL through electrostatic interactions due to the pres-
ence of a basic spine formed by positively charged amino
acids.27–30 LOX-1 is a multivalent scavenger receptor respon-
sible for the internalization, beyond ox-LDL, of a variety of
different macromolecules, including activated platelets, apop-
totic bodies, bacteria, and advanced glycation end products
(AGEs).31 Its expression is up-regulated in many pathological
conditions affecting the cardiovascular system and it has been
associated with atherosclerosis, obesity and inflammation.32
Recent studies have demonstrated that LOX-1 is up-regulated
in many cancer types including bladder, cervix, mammary
gland, lung, and colorectal, suggesting its involvement in
tumor development.33–35 During the past years, our group,
with a combined simulative and experimental approach, has
characterized the molecular mechanism of LOX-1 binding
activity36,37 and set up a model cell system based on the
ectopic expression of the human isoform of the receptor.38
This system allows a very high expression level of LOX-1 recep-
tors on the cell membrane, mimicking the in vivo character-
istics of up-regulation typical of pathological states.35 Taking
advantage of this cell system, we have previously characterized
the LOX-1-mediated cellular uptake of octahedral nanocages.24
Here we use the same cellular system for investigating either
the influence of size and shape along with the presence of
covalent or non-covalent bonds on the DNS receptor-mediated
cellular uptake. We assembled tetrahedral and octahedral
nanocages, rod-shaped chainmails, square box and rectangu-
lar DNA origami structures and compared them for their stabi-
lity in serum, cell membrane binding, internalization
efficiency and intracellular degradation rate.
Materials and methods
Preparation of DNS
Tetrahedral and octahedral nanocages. All oligonucleotides
used for the assembly of non-covalent and covalent bio-
tinylated-DNA tetrahedral (TD) and octahedral (OD) nanocages
were HPLC purified and purchased from Sigma-Aldrich.
Sequences of oligonucleotides are reported in the ESI S1,
Table S1† and in Vindigni et al.,24 respectively. DNA nanocages
were prepared as previously described.24
Chainmails. All azide/alkyne-oligonucleotides used for the
assembly of non-covalent and covalent biotinylated chainmails
(CM) were HPLC purified and purchased from Metabion,
Germany. Sequences of the oligonucleotides are reported in
the ESI S2, Table S2.† DNA chainmails were folded by cooling
a buffer solution (1 × TE, 20 mM MgCl2) containing azide/
alkyne-oligonucleotides from 80 °C to 65 °C in steps of 1 °C
min−1 followed by a slower ramp from 65 °C to 25 °C in steps
of 0.5 °C every 12 min, as previously described.39 Namely, five
bct-ODNs (body functional click tiles) and three hct-ODNs
(head functional click tile) were mixed with 16 ct-ODNs (click
tile). Thus, through a single one-pot CuAAC three different
kinds of click reactions are simultaneously accomplished.
Specifically, 24 strands undergo catenation, five positions are
labeled with an external azide and three “head” alkyne
residues are conjugated with a strand carrying an additional
functionality. A graphical representation of the components of
the chainmail participating in the folding procedure and the
subsequent one-pot click reaction on the structure is shown in
the ESI S3, Fig. S1.†
Square box (SBO) and rectangular (RO) origami. DNA
origami structures were assembled in one-pot reactions con-
taining single-stranded M13 DNA, unmodified and biotin-
modified staple strands in TAEM buffer (Tris-acetate pH 8
40 mM, EDTA 1 mM and Mg(OAc)2 12.5 mM) using an over-
night thermal annealing ramp from 90 °C to 10 °C. Excess
staple strands were removed by 100k Amicon filters as
described by the manufacturer (Merck Millipore).40
TEM studies
The structural integrity of DNA nanostructures was verified
using negative-stain transmission electron microscopy (TEM).
The TEM samples were prepared by dropping 5 μL of
0.1–0.3 μg μl−1 DNS solution in TAE (TD, OD and CM) or
TAEM (RO and SBO) onto a glow-discharged thin carbon-
coated CF400-CU-UL grids (EMS, Hatfield, PA, USA) for
1.5 min. The grids were quickly blotted and immediately
stained using a negative stain procedure of 2 consecutive
rounds of addition of 2% uranyl formate solution for 5 and 20
s, respectively (5 s + 10 s for the rectangular origami), each fol-
lowed by a blotting step. After the second stain-blotting step,
samples were left to air dry prior to imaging.
Imaging was performed with a Tecnai G2 Spirit electron
microscope (FEI Company) operated at 120 kV using a Lab6
electron gun. Image acquisition was done using a bottom-
mounted TVIPS CMOS 4k camera (TEM-cam-F416) at magnifi-
cations of ×42.000–×52.000.
DNS biotinylation
Biotinylated TD, OD and CM were obtained using oligonucleo-
tides modified with biotin through copper(I)-catalysed azide/
alkyne cycloaddition (CuAAC, click reaction), as described in
the ESI, S3.† Biotinylated RO and SBO were assembled using
biotin-modified staple strands, generated reacting the terminal
transferase enzyme with biotinylated dUTPs.41
Cell cultures and transfection
COS-7 cells, a monkey kidney fibroblast-like cell line, were
grown in DMEM (Dulbecco’s Modified Eagle’s Medium;
Biowest) supplemented with 10% fetal bovine serum (FBS,
Gibco), L-glutamine 1 mM (Sigma Aldrich), sodium pyruvate
1 mM (Biowest) and 100 U ml−1 penicillin–streptomycin
(Euroclone). For the expression of LOX-1 receptors, human LOX-1
was subcloned into pEF/V5-His vectors (Invitrogen) and used for
transiently transfecting COS cells, as previously described.38
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Biotinylated DNS were incubated in 10% FBS at 37 °C for
different times. To prevent the denaturation of origami struc-
tures, RO and SBO stability experiments were performed by
supplementing 10% FBS with 6.25 mM MgCl2. After incu-
bation, each DNS sample was treated with proteinase K
(100 μg mL−1) for 1 h at 37 °C and protein digestion was
stopped by adding PMSF to a final concentration of 5 mM.
Samples were mixed with loading buffer (Tris-Cl 500 mM pH
6.8; glycerol 20%; SDS 4%; Bromophenol Blue 0.02%), run on
1% agarose gel in TBE (Tris-Cl 89 mM pH 8, boric acid 89 mM,
EDTA 2 mM), supplemented with 6.25 mM MgCl2 for non-
covalent DNS, and blotted.
Purification of DNS from cell lysates and blotting
Cells were plated in 48 wells per plate at a density of 3 × 104
cells per well, transiently transfected with LOX-1-V5 and, after
24 hours, incubated with 6 µg mL−1 of biotinylated DNS for
different times at 37 °C. DNSs were purified from cell lysates
and treated with proteinase K (100 μg mL−1) for 1 h at 37 °C,
as previously described.24 Samples were run on 1% agarose gel
in TBE, transferred to a positively charged nylon membrane
(Zeta Probe, BioRad) for 30 min at 23 V (SemiDry Transfer Cell,
BioRad) and treated as previously described.24 Biotin detection
was carried out using streptavidin–HRP (Abcam) and visual-
ized by enhanced chemiluminescence (ECL EXTEND,
Euroclone). For image processing and densitometric analysis,
photographic films were digitized by scanning. Bands were
analyzed using ImageJ software. Values were calculated using
GraphPad Prism and expressed as a mean ± SEM.
Confocal analysis
COS cells were seeded on poly-L-lysine-coated glass cover-
slides, transfected with LOX-1-V5 and incubated with biotiny-
lated DNS. Binding experiments at 4 °C were performed as
previously described.42 Uptake experiments were performed by
incubating cells with DNS in DMEM 10% FBS for different
times at 37 °C. Cells were then washed in Phosphate-Buffered
Saline (PBS), fixed with 4% paraformaldehyde and permeabi-
lized with Tris-HCl 0.1 M pH 7.6/Triton 0,1% for 4 min.
Co-localization experiments were performed as previously
described.24 Biotinylated DNS were detected with streptavidin-
FITC (Jackson ImmunoResearch); the LOX-1 receptor was visual-
ized using Mab anti-V5 (Invitrogen) and lysosomes were detected
using rabbit monoclonal anti-LAMP-1 antibody (Cell Signaling
Technology). Rhodamine Red-X-conjugated AffiniPure donkey
anti-mouse IgG and Red-X-conjugated AffiniPure donkey anti-
rabbit IgG (Jackson ImmunoResearch) were used as secondary
antibodies. Nuclei were stained with DAPI (Invitrogen). At the
end of incubation, coverslips were washed in PBS and mounted
with ProLong Gold Antifade Mountant (Thermofisher). Images
were obtained with a laser confocal fluorescence microscope
Olympus FV1000 at 60× magnification.
Results
Design, assembly, and characterization of DNS
Different covalently linked DNA structures (DNS) and non-
covalent structures (ncDNS) were designed and assembled
(Fig. 1A). Tetrahedra (TD) and octahedra (OD) are composed of
four and eight oligonucleotides, respectively (ESI, S1† and
Vindigni et al.24). For covalent TD and OD, DNA ligase is
added after their assembly, in order to link the strands
through a 5′–3′ covalent bond. Rod-shaped chainmail struc-
tures (CM) are assembled using 5′-azide, 3′-alkyne-modified
oligonucleotides reported in the ESI, S2.† For covalent CM,
5′-azide, 3′-alkyne-modified oligonucleotides are covalently
connected by chemical ligation to form rings and interlocked
DNA single strands (ESI, S3†). Square box (SBO) and rectangu-
Fig. 1 (A) Computer models of DNS used in this study. From left to right: Tetrahedral (TD) and octahedral (OD) nanocages, rod-shaped chainmail
(CM), square box (SBO) and rectangular (RO) origami. (B) TEM images of each of the DNS used in the study. Scale bars: 50 nm.
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lar (RO) origami are non-covalently linked structures,
assembled from a 7249-nucleotide-long single-stranded M13
DNA (the scaffold strand), folded into a defined shape by hun-
dreds of shorter staple strands using thermal annealing in a
one-pot reaction. The structural integrity of each DNS shape
was verified by negative-stain transmission electron
microscopy (TEM) (Fig. 1B). All constructed DNS were free
from aggregation and were predominantly found in the mono-
meric state.
Biotin groups were added to the DNS. In detail, TD and OD
have one biotin molecule bound per cage, CM contains 5 and
RO and SBO structures have 32 biotin molecules for each
structure.
Stability of DNS in fetal bovine serum
As an important prerequisite for the use of DNS in biomedical
applications, we investigated the in vitro stability in biological
fluids at the physiological temperature of 37 °C and compared
their resistance to nuclease digestion. After incubation with
10% fetal bovine serum (FBS) for different time intervals, non-
covalent and covalent DNSs were run in 1% agarose gel and
blotted to examine their structural integrity (Fig. 2 and ESI
S4†). The presence of biotin molecules inserted in the struc-
tures allows the detection of DNS through a streptavidin–HRP–
biotin reaction in DNA blots.
As shown in Fig. 2, non-covalent ncTD, ncOD and ncCM are
stable for at least 4 h in 10% FBS at 37 °C and then the ncDNS
are degraded as a function of time (Fig. 2A, lanes 1–5; 2B,
lanes 1–4 and 2C, lanes 1–4). The relative intensity of each
band, quantified by densitometric analysis using ImageJ soft-
ware, was normalized to the intensity of the band corres-
ponding to the input and reported in the graph. The half-lives
of ncTD, ncOD and ncCM in FBS are 25 ± 2.4, 15 ± 2.7 and
17 ± 1.6 h, respectively, calculated by the relative intensity of
each band visualized through a DNA blot. Instead, covalent
TD, OD and CM are stable up to 24 h in 10% FBS at 37 °C
before gradual degradation (Fig. 2A, lanes 6–11; 2B, lanes
6–10; 2C, lanes 5–10), indicating higher resistance than non-
covalent DNS. In particular, the presence of covalent bonds in
TD, OD and CM extends the half-life in 10% FBS to 48 ± 2.5,
27 ± 1.9 and 66 ± 2.1 h, respectively.
Regarding origami structures, the non-covalently-linked
ROs are fully stable in 10% FBS at 37 °C for 4 h (Fig. 2D, lanes
1–3). Between 4 and 24 h, a lower molecular band of about
1 kb is visible, suggesting a partial disassembly (Fig. 2D,
lanes 4). At 48 h, no band with the same mobility as the input
is detectable, while the intensity of the lower-molecular-weight
band increases, indicating that the original RO structures are
almost fully degraded (Fig. 2D, lane 5). It is worth noting that
the intensity of the 2 kb origami band increases when the
lower molecular weight band appears (Fig. 2D, lane 4). This
may be explained by an increased exposure of the biotin
groups upon partial unfolding of the origami structure. SBO
structures show similar behavior in 10% FBS at 37 °C (ESI,
S4†).
Receptor-mediated entry of DNS into LOX-1-expressing cells
Binding and uptake of the DNS in mammalian cells were
monitored in COS fibroblasts transiently transfected with a
plasmid encoding for the human full-length LOX-1 receptor,
containing a V5 tag at the C terminus (LOX-1-V5), as previously
described.24 This cell system allows a very high expression
level of functional LOX-1 receptors and a high transfection
efficiency (about 40% of total cell population). Since not-trans-
fected COS cells do not express endogenous LOX-1, the study
of the specific interaction between LOX-1 receptors and DNS
can be studied within the same cell population.
Twenty-four hours after transfection with the LOX-1 recep-
tor gene, COS cells were incubated with the biotin-labeled DNS
for 1 h at 4 °C or different times at 37 °C and stained with
anti-V5 antibodies and streptavidin–FITC, for visualizing
LOX-1 receptors and biotinylated DNS, respectively. DAPI was
used for localizing the nuclei. DNS binding to the cells at 4 °C
was visualized by confocal analysis as intense dot-like green
fluorescence in association with the outer surface of the
plasma membrane (Fig. 3A, B, and 4, panels a and b). The
finding that an almost identical dot-like fluorescence is
obtained when cells are stained with Mab anti-V5 IgG, which
selectively visualizes transfected LOX-1 receptors (ESI, S5†), is
consistent with an interaction between DNS and LOX-1
receptors.
As already demonstrated for octahedral DNA
nanocages,19,24 DNS and LOX-1 receptors cannot be visualized
simultaneously in a binding experiment at 4 °C, since DNS
and anti-V5 antibodies compete for the same binding site on
LOX-1 receptors, when situated on the cell surface. However,
the co-detection of intracellular LOX-1 receptors and interna-
lized DNS in the same cell is possible since newly synthetized
LOX-1 is present in an intracellular pool in the endoplasmic
reticulum and Golgi apparatus.43 To enable their co-detection,
DNS were incubated with cells for different times at 37 °C and
confocal microscopy used for visualizing internalized DNS and
intracellular LOX-1 receptors. Fig. 3 shows representative
images in which LOX-1-expressing cells (red fluorescence,
Fig. 3A and B, panels c) exhibit internalized TD (green fluo-
rescence, Fig. 3A, panels d and e) and CM (Fig. 3B, panels d
and e) after 1 h incubation at 37 °C. Notably, both TD and CM,
notwithstanding the different sizes and shapes, are efficiently
internalized in LOX-1-expressing cells. TD and CM nano-
structures appear as fluorescent dots in the cytoplasm, larger
than those seen in the binding experiments (compare panels a
and d of Fig. 3A and B), confirming that TD and CM are dis-
tributed in endocytic vesicles that tend to fuse together to
form larger endosomes, as shown for octahedral cages in
Vindigni et al.24
As shown for TD and CM, also RO nanostructures bind to
LOX-1 receptors at the cell surface and are distributed in small
green fluorescent dots (Fig. 4, panels a and b). For the co-
detection of RO and LOX-1 in the same cells we incubated for
different time intervals at 37 °C RO structures with LOX-1
expressing cells and analyzed cells with confocal microscopy.
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Fig. 2 In vitro stability of biotinylated non-covalent (ncDNS) and covalent DNS. DNA blot analysis of (A) ncTD and TD (B) ncOD and OD (C) ncCM
and CM and (D) RO structures incubated with 10% FBS for different time intervals, as indicated. Purified DNS before incubation with serum proteins
(time 0) are shown in lane 1 of each panel. The graphs show the densitometric analysis, performed by using ImageJ software, of three different
experiments. The relative intensity of each band was normalized to the intensity of the band corresponding to each time 0 (lane 1) and reported in
the graph. In (D) the dotted line represents the normalized band intensity of the RO origami obtained summing the intensity of the two visible bands
and calculating the percentage of the upper band compared to the total. Values are expressed as an average ± SEM.
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After 1 h at 37 °C, RO structures appear in many small
green fluorescent dots inside LOX-1-positive cells (red fluo-
rescence) (Fig. 4, panels c and d). At 3 h of incubation at 37 °C,
RO structures are detectable inside cells in larger fluorescent
dots (Fig. 4, panel g), as already observed for TD and CM after
1 h (Fig. 3A and B, panels d). The merged images (Fig. 4,
panels e and h) clearly demonstrate that RO structures are
internalized only in LOX-1-positive cells (yellow and orange
color in merged images). Co-detection experiments were
repeated for SBO structures (ESI S6†). Fig. S6† shows represen-
tative confocal images in which LOX-1-expressing cells have
unequivocally internalized SBO structures.
Notably, no binding or internalization of different biotiny-
lated DNS was detected in not-transfected cells (ESI, S7†).
Since the scavenger LOX-1 receptor interacts with negatively
charged molecules, competition assays were performed to test
the specificity of the recognition for DNS (ESI, S8†). We show
that a single-stranded oligonucleotide with a random
sequence, at a concentration 10 times higher than TD, does
not impair the TD binding to LOX-1 receptors (Fig. S6,†
panel b). As a control, non-biotinylated assembled TD struc-
tures compete for the binding of biotinylated TD and lead to
complete loss of binding, visualized by streptavidin–FITC
(Fig. S6,† panel c).
Intracellular stability of DNS
Since confocal analysis does not allow verifying whether DNA
nanostructures are partially degraded or maintain their struc-
tural integrity inside cells, we evaluated the integrity of inter-
nalized DNS by DNA blot after DNS purification from cells. In
detail, structural stability during the internalization process
was monitored by purifying biotinylated DNS after incubation
Fig. 3 Co-detection of LOX-1 receptors with TD and CM in COS transfected cells. Confocal analysis of double fluorescence of LOX-1-V5-expres-
sing COS cells incubated with biotinylated TD (A) and CM (B) for 1 h at 4 °C (panels a and b) and 1 h at 37 °C (panels c–e). Intracellular LOX-1 recep-
tors (panel c) were visualized using mouse monoclonal anti-V5 antibody (red), and biotinylated DNS were detected by using streptavidin-FITC
(green). The nuclei were stained with DAPI. White arrows in the merge images indicate not-transfected cells. Scale bar: 20 μm.
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with LOX-1-transfected COS cells at 37 °C for different time
intervals. Samples were analyzed in 1% agarose gels, trans-
ferred onto Zeta-Probe membranes and visualized by using
streptavidin–HRP (Fig. 5 and 6 and ESI S9–S11†). Covalently
linked TD and CM, purified from cells after 1, 3 and 18 h of
incubation (Fig. 5A and B), have electrophoretic mobility com-
parable to the input (lane 4 in Fig. 5A and lane 1 in Fig. 5B),
indicating that they remain intact inside cells for at least 18 h.
The densitometric analysis allowed us to calculate the amount,
expressed in ng per 106 cells, of intact TD and CM internalized
by LOX-1-expressing COS cells at different times (Fig. 4C). After
1 h incubation, we detect 140 ± 33 ng per 106 cells and 261± 69
ng per 106 cells internalized TD and CM, respectively, increas-
ing to 489 ± 107 ng per 106 cells and 541 ± 104 ng per 106 cells
at 3 h, respectively. After 18 h of incubation, the amount of
intact structures inside cells decreases to 348 ± 65 ng per 106
cells for TD and 406 ± 74 ng per 106 cells for CM, suggesting
that DNSs undergo intracellular degradation associated with
the LOX-1 pathway. The amount of intact internalized OD in
LOX-1-expressing COS cells, calculated by setting up identical
Fig. 4 Co-detection of LOX-1 receptor with RO in COS transfected cells. Confocal analysis of double fluorescence of LOX-1-V5-expressing COS
cells incubated with biotinylated RO for 1 h at 4 °C (panels a and b), 1 h at 37 °C (panels c–e) and 3 h at 37 °C (panels f–h). Intracellular LOX-1 recep-
tors (panels c and f) were visualized using mouse monoclonal anti-V5 antibody (red), and biotinylated origami were detected by using streptavidin-
FITC (green). The nuclei were stained with DAPI. White arrows in the merge images indicate not-transfected cells. Scale bar: 20 μm.
Fig. 5 LOX-1-mediated uptake of covalent TD and CM in cells. Representative DNA blots of cell extracts obtained from LOX-1-transfected COS
cells incubated with 6 μg ml−1 of biotinylated TD (A) and CM (B) for 1, 3 and 18 h at 37 °C. DNS were detected with streptavidin-HRP. (C) Histogram
shows the amount of internalized TD and CM detected in cell extracts of LOX-1-transfected cells at different times, as indicated and expressed in ng
per 106 cells. For image processing and densitometric analysis, photographic films were digitized by scanning. Bands were analyzed by using
ImageJ software. Values were normalized for the total number of LOX-1-transfected cells and expressed as a mean ± SEM.
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experiments is 95 ± 15 and 219 ± 9 ng per 106 cells after 1 and
3 h, respectively, and 246 ± 25 ng per 106 cells after 18 h,
values of the same order of magnitude of that obtained with
TD and CM.19 It is worth noting that not-transfected COS cells,
after 1 h of incubation at 37 °C, internalize very low amounts
of TD and CM, namely 4.6 ± 0.7 ng per 106 cells and 8.4 ± 0.9
ng per 106 cells, respectively (ESI, S9†).
Non-covalently linked TD, OD and CM structures are less
stable than their covalently linked forms, as shown in Fig. 2.
The lower stability of ncOD becomes more evident when we
evaluated their stability inside COS-LOX-1 cells (ESI, S10†).
Fig. S8A† shows that ncODs are barely detectable in cell lysates
after 3 h incubation and no intact structures are found after
18 h of incubation.
Fig. 6 shows a representative DNA blot of RO structures
extracted after incubation with cells for 1, 3 and 18 h. After 1 h
incubation, the origami undergoes a degradation process that
leads to the formation of a smaller band at 1 kb. The 2 kb
band, corresponding to the intact structure before incubation
with cells (input, Fig. 6A, lane 1), becomes barely visible after
1 h (Fig. 6A, lanes 2, 3 and 4). As shown in Fig. 6B, a 4×
exposure of the blot is necessary to reveal the intact 2 kb band.
The smaller 1 kb band accumulates in cells in a time-depen-
dent manner. The densitometric analysis allowed us to evalu-
ate the amount of intact RO (2 kb band) inside cells expressed
in ng per 106 cells at different time points. After 1 and 3 h of
incubation (Fig. 6C), we calculate 65 ± 13 ng per 106 cells and
117 ± 11 ng per 106 cells and only a tiny amount of intact RO
was detectable after 18 h incubation. Similar results were
obtained for SBO structures after internalization in cells (ESI,
S11†). Notably, the analysis of the RO structures in the con-
ditional medium at the same time points (Fig. 6A, lanes 5, 6
and 7), shows that the structures are intact outside the cells
and, only after 18 h incubation, the band at 1 kb becomes
evident. This result indicates that RO structures initiate a
degradation process only after cell internalization.
To study whether endocyted RO structures follow a degra-
dation pathway where they are trafficked toward lysosomes, we
incubated LOX-1-transfected COS cells with biotinylated RO at
different time intervals. By performing a double immunofluor-
escence analysis using streptavidin–FITC and antibodies
against the lysosomal-associated membrane protein (LAMP-1),
we could track biotinylated-DNA structures and lysosomes.
Fig. 7 shows representative confocal images of cells incubated
for 1 and 3 h with 4 μg mL−1 of RO. After 1 h, RO structures
(green fluorescence, panel a) appear in small vesicles in the
cytoplasm of LOX-1-expressing cells and only very few of them
co-localize to lysosomes (Fig. 7, panels b and c). After 3 h of
incubation at 37 °C, vesicles become larger and some of them
appear to fuse with lysosomes (see the merged image in
panel f ). The correlation of the intensity values of the green
and red pixels was evaluated by the Pearson’s correlation
coefficient (PCC).44 In our analysis, the PCC values for RO and
LAMP-1 marker is very low (0.18) after 1 h of incubation and
increases to 0.38 after 3 h of incubation, indicating increased
co-localization. This finding indicates that the internalized RO
structures finally reach lysosomes after extended incubation
times.
Discussion
DNA nanostructures of different sizes (from 8 to 80 nm) and
shapes (tetrahedral, octahedral, cylindrical, square box and
rectangular) are efficiently recognized by the scavenger recep-
tor LOX-1 and internalized through a receptor-mediated
mechanism. The recognition process occurs independently of
the covalent or non-covalent nature of DNS that strongly per-
turbs their stability. Presence of covalent bonds make these
structures more stable in biological liquids compared to the
non-covalent isoforms (ncTD, ncOD and ncCM in Fig. 2A–C).
In line with this observation, the half-life in serum of square
box and rectangular origami structures is similar to that
obtained with non-covalent DNS (Fig. 2D).
The LOX-1 receptor-mediated endocytosis of the natural
substrate ox-LDL leads, after 1 hour incubation, to the for-
mation of visible vesicles within cells that typically increase in
volume over time, indicative of a vesicle fusion phenomenon.45
Despite the efficient recognition of all DNS by cell surface-
exposed LOX-1 receptors, we find differences in the kinetics of
intracellular entry of the covalent tetrahedra and chainmails
Fig. 6 LOX-1-mediated uptake of RO origami in cells. (A)
Representative DNA blot of cell lysates and conditioned media obtained
from LOX-1-transfected cells incubated with 6 μg ml−1 of biotinylated
RO for 1, 3 and 18 h at 37 °C. DNS were detected with streptavidin-HRP.
(B) 4× exposure of DNA blot shown in A. (C) Histogram shows the
amount of internalized RO detected in cell extracts of LOX-1-trans-
fected cells at different times, as indicated and expressed in ng per
106 cells. Bands were analyzed by using ImageJ software. Values were
normalized for the total number of LOX-1-transfected cells and
expressed as a mean ± SEM.
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when compared to the much larger square box and rectangular
origami. Tetrahedral cages and chainmail, after incubation
with LOX-1 expressing cells for 1 h at 37 °C, are found in small
dots that tend to fuse in larger vesicles within a few hours,
indicating that they traffic through lysosomes for destruction,
as we have also demonstrated in the case of octahedral DNA
cages.19,24 When cells are incubated with RO or SBO struc-
tures, most of the green fluorescence is diffused into the cyto-
plasm in very small dots after 1 h at 37 °C (Fig. 4 and ESI, S6†).
Co-localization analysis with the lysosomal marker LAMP-1
shows that most of these dispersed fluorescent dots are not co-
localizing with lysosomes and, only after 3 h, vesicles become
larger and some of them appear to fuse with lysosomes, indi-
cating that they traffic towards lysosomes as TD, OD and CM,
although with an apparent different kinetics. The difference
in intracellular distribution of RO and SBO compared to TD
and CM can be explained at least with two putative events,
which are not mutually exclusive: (i) a rapid disassembly and
release of the partially broken origami from vesicles to the
cytosol or (ii) a different trafficking kinetics of origami struc-
tures compared to TD and CM, influenced by size and
compactness.
It is well known that non-covalent DNS can be sensitive to
divalent cation depletion.46 Although high Mg2+ concentration
is required for the assembly of all DNS described here, the
stabilities of ncTD, ncOD and ncCM are not sensitive to post-
assembly alteration in Mg2+ concentrations or to its depletion,
while RO and SBO structures need at least 6 mM Mg2+ for
maintaining their structural integrity in solution.40 DNA
origami susceptibility to divalent cations depletion provide a
supporting argument for the first hypothesis. Notwithstanding
that the intracellular Mg2+ concentration ranges from 5 to
20 mM, 95% of it is associated with proteins, phospholipids,
nucleic acids, chromatin and nucleotides and only a small per-
centage (1–5%) is present in its ionized form.47 Thus, the low
available Mg2+ concentration (ranging from 0.25 to 1 mM) may
induce a rapid disassembly of the origami structures inside
endocytic vesicles after entry in cells and release of partially
broken origami in the cytoplasm (Fig. 4 and 6).
The nanoparticle visualization system used in this study,
based on the recognition of the biotinylated structures with
streptavidin, allows verifying the state of integrity of the par-
ticles inside cells, as a function of time. We find that the co-
valently linked DNA structures display higher stability in cells
than the non-covalently linked ones. Covalently linked TD,
OD, and CM remain intact inside cells at least for 18 h. On the
other hand, origami structures, already after 1 h, appear to
partially disassemble and degrade in a smaller structure of
1 kb band, still present after 24 hours inside cells. At present,
the shape of this new structure is not clear. It may represent a
more compact origami inside cells, but we need a more in-
depth analysis of it to prove this. It is worth noting that adding
covalent bonds to origami structures results in enhanced resis-
tance against nuclease activity and in a longer half-life in 10%
FBS at 37 °C, as recently reported.48
In conclusion, the scavenger receptor LOX-1 very efficiently
binds and internalizes a broad family of DNA nanostructures,
indicating that they can be used for efficient and selective
delivery of useful cargo to the cells. However, the DNS studied
in this work have a different fate and lifetime inside cells. RO
and SBO structures are rapidly degraded whilst covalently
linked tetrahedra, octahedra or rod-shaped chainmails are
more stable. LOX-1 expression is not only markedly increased
in many pathological conditions affecting the cardiovascular
system but its up-regulation has been associated with tumor
development in many cancer cells, including bladder, cervix,
Fig. 7 Co-localization analysis of RO structures with the lysosomal marker LAMP-1. Double immunofluorescence of LOX-1-V5-expressing COS
cells incubated with RO at 37 °C for 1 h (panels a–c) and 3 h (panels d–f ). Biotinylated ROs were detected using streptavidin–FITC (green, panels a
and d) and lysosomes were visualized using anti-LAMP-1 antibody (red, panels b and e). The nuclei were stained with DAPI. Merged images are
shown in panels c and f. Co-localization analysis was performed using Imaris software. Scale bar: 20 μm.
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mammary gland, lung, and colorectal, indicating that it is an
interesting target molecule in different diseases.33,34
Depending on the desired effect, different DNS may be pre-
ferred, such as, for example, origami structures for rapid burst
drug release and covalent DNS for slower release.
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S1. Sequences of oligonucleotides used for the assembly of non-covalent and covalent DNA 
tetrahedra
Unmodified oligonucleotides were HPLC purified and purchased from Sigma Aldrich. The sequences 
of the oligonucleotides are reported in Table S1. The 5’ of each oligonucleotide is phosphorylated. 
TTTTT represents a short non-pairing spacer inserted within the strands as a DNA junction at each 
vertex of the assembled 3D structure. OL3BIO has a biotin tetra-ethylene-glycol molecule (BtndT) at 




3BIO 5’-P-CGCGTCGTCTTTTTTTGTAAGTATGATTGTAGGGTTTTTTGCGCCGTGGAATTAGTGGTTTTTTTGCTGGAATG -3’ 
4 5’-P-CATACTTACTTTTTTTCGGGAGAGTGGGTTTGCCTTTTTTTGGAGTAAGGAAGGAGCAGCTTTTTTTCCCTACAAT-3’
Table S1. Sequences of the oligonucleotides used for the assembly of Bio-DNA tetrahedra. In red 
is depicted the biotinylated T in OL3BIO.
S2. Sequences of oligonucleotides used for the assembly of non-covalent and covalent DNA 
chainmails
5’-Azide, 3’-Alkyne oligonucleotides were HPLC purified and purchased from Metabion, Germany. 
The sequences of the oligonucleotides are reported in Table S2. After folding, the oligonucleotides 
form a 6-helix bundle in which the 5’ and 3’ click functionalities are pre-organized and ready to react 


























Table S2. Sequences of the oligonucleotides used for the assembly of DNA chainmails. 
Z: Azide; X: Alkyne 
S3. Click reaction 
Starting from the original design previously described1, eight click tail oligonucleotides (ODN) were 
replaced with 5 bct-ODNs having the same sequence with an extra alkyne moiety and three hct-ODNs 
having the same sequence with an extra strand carrying an optional modification. The click reaction 
was performed using 40 μl of the solution containing the folded nanostructures (0.5 μM) where it was 
added 6 mg of the heterogenous Cu catalyst, 10 µL of Cu ligand Tris (benzyltriazolylmethyl) amine 
(THPTA baseclick GmbH) 0,1 M and 1 µL of Biotin-Peg3-Azide (baseclick GmbH) 1 mM. The 
solution was then incubated at 32 °C for 5 hours gently mixing at 200 rpm. The mixture was then 
transferred in a fresh vial and the Cu catalyst discharged. The sample was analyzed without any 
further purification step. For cell experiments, the chainmails were purified via EtOH precipitation.
Figure S1. Schematic representation of the DNA chainmail functionalization. After the 
folding reaction via one-pot click reaction, it is possible to close the click tails leading to chainmail 
formation and, at the same time, to labeling the structure with biotin. Nomenclature: bct-ODN = body 
(functional) click tile; hct-ODN = head (functional) click tile.
 
S4. Stability of square box origami structures in 10%FBS 
Square box origami (SBO) were incubated at 37°C with 10% fetal bovine serum (FBS) for different 
time intervals, as indicated. After incubation, SBO samples were run in 1% agarose gel to examine 
the structural integrity. The presence of 32 biotin molecules allows the detection of SBO through a 
streptavidin-HRP-biotin reaction in DNA blots. 
As shown in Figure S4, SBO structures start to lose their integrity between 3 and 24 h. Notably, the 
SBO loss of structure and degradation causes an increase in the intensity of the signal of the band 
detected by the streptavidin-biotin reaction in DNA blot (lane 4) as observed for RO (Figure 2, lanes 
4 and 5).
Figure S2. Stability of biotinylated SBO in serum. DNA blot analysis of SBO incubated with 
10% FBS. 20 ng of SBO before incubation with serum proteins (time 0) are shown in lane 1. 
Incubation times are indicated under the gel.
S5. Membrane LOX-1 receptors visualized with Mab anti-V5 IgG 
COS cells were plated on poly-L-lysine coated glass slides and then transfected with pEF/V5-LOX-
1, a plasmid encoding for the full-length LOX-1 receptor containing a V5-tag at the C-terminus 
(LOX-1-V5). After 24 hours from transfection, cells were incubated with Mab anti-V5 for 1 h at 4°C 
for visualizing LOX-1-V5 receptors expressed at the cell surface (Figure S5). Cells were washed in 
PBS, fixed in 4% paraformaldehyde and neutralized with NaBH4. Rhodamine Red-X-conjugated 
AffiniPure donkey anti-mouse IgG was used as secondary antibody and nuclei were stained with 
DAPI. In Figure S5 LOX-1 receptors are represented by red fluorescent intense dots, indicating that 
the receptors localize on the outer surface of the plasma membranes. It is worth noting that within 
transfected LOX-1 cells some cells (white arrows) do not express LOX-1 according to the transfection 
efficiency of 40% and do not show any red membrane fluorescence around the blue nuclei.
Figure S3. Confocal analysis of LOX-1-expressing COS cells incubated with Mab anti-V5 for 1 h 
at 4°C. White arrows indicate some not-transfected cells. Images were obtained with a laser confocal 
fluorescence microscope Olympus FV1000 at 60X magnification and processed by IMARIS 
software. Scale bar: 20 μm.
S6. Co-detection of LOX-1 receptors and SBO structures in LOX-1 expressing COS cells.
For the binding experiment, COS cells were transfected with pEF/V5-LOX-1 plasmid and, after 24 
h, incubated with biotin-labeled SBO origami (4 µg/mL) for 1 h at 4°C, fixed in 4% paraformaldehyde 
and neutralized with NaBH4. Biotinylated SBO were detected with streptavidin-FITC (Jackson) and 
nuclei stained with DAPI (Invitrogen). In Figure S6, panels a and b, SBO origami are detected as 
green fluorescent intense dots, indicating that they localize on the plasma membrane surface.
For co-detection of LOX-1 receptors and SBO structures, LOX-1-transfected COS cells were 
incubated with biotinylated SBO (4 µg/mL) for 1 h at 37°C, fixed with 4% paraformaldehyde and 
permeabilized with Tris-HCl 0.1M pH 7.6/Triton 0,1%, for allowing the detection of both internalized 
structures and intracellular LOX-1 receptors. Cells were stained with anti-V5 antibodies and 
streptavidin−FITC, for visualizing LOX-1 receptors and biotinylated SBO respectively and with 
DAPI for localizing the nuclei. Figure S6 shows representative confocal images in which 
unequivocally LOX-1-expressing cells (red fluorescence, panel c) have internalized SBO structures 
(green fluorescence, panels d and e).
Figure S4. Binding of SBO to LOX-1-expressing COS cells and co-detection of LOX-1 
receptors and SBO structures. Confocal analysis of LOX-1-expressing COS cells incubated with 
biotinylated SBO for 1 h at 4°C (panels a and b) and with biotinylated SBO for 1 h at 37°C (panels 
c, d, and e). SBO were detected by using streptavidin−FITC (green) and LOX-1 receptors were 
visualized using anti-V5 antibody (red). Nuclei were stained with DAPI (blue). White arrows show 
not-transfected cells. Images were obtained with a laser confocal fluorescence microscope Olympus 
FV1000 at 60X magnification and processed by IMARIS software. Scale bar: 20 μm.
S7. Confocal analysis of biotinylated DNS internalized in not-transfected COS cells 
compared to LOX-1 transfected cells.
In order to demonstrate a specific binding between DNS and LOX-1 receptors, we have performed 
uptake experiments on LOX-1 transfected (COS-LOX-1) or not-transfected (COS nt) COS cells. In 
detail, cells were incubated with biotinylated DNS (10 µg/mL for TD and CM and 4 µg/mL for RO) 
for 1 h at 37°C, fixed with 4% paraformaldehyde and permeabilized with Tris-HCl 0.1M pH 
7.6/Triton 0,1%, for allowing the detection of the internalized structures. Cells were stained with 
streptavidin−FITC for visualizing biotinylated DNS and with DAPI for localizing the nuclei. Figure 
S7 shows representative confocal analysis in which LOX-1-expressing cells (panel a, c, and e) have 
internalized biotinylated DNS while no green fluorescence was detectable inside the COS nt cells 
(panels b, d, and f) for any of the DNS tested, indicating a LOX-1-dependent cellular uptake of DNS. 
Figure S5.  Representative confocal images of DNS uptake in COS cells. COS-LOX-1 (panels 
a, c, and e) and COS nt cells (panels b, d, and f) were incubated for 1 h at 37°C with biotinylated TD, 
CM, and RO. Biotinylated DNS were detected with streptavidin-FITC and nuclei were blue stained 
with DAPI. Images were obtained with a laser confocal fluorescence microscope Olympus FV1000 
at 60X magnification and processed by IMARIS software. Scale bar, 20 μm.
S8. Competition assays. 
To study the specificity of LOX-1 recognition, two competition binding assays were performed, one 
in the presence of 10 times more concentrated single stranded oligonucleotide and one in the presence 
of non-biotinylated DNS. Figure S8 shows representative confocal images of the competition assays 
performed by incubating LOX-1 expressing cells with 144 nM biotinylated tetrahedral nanocages 
(Bio-TD) in the absence (panel a), in the presence of 1,4 µM 29 nt single-stranded oligonucleotide 
with random sequence (10x oligo, panel b) and in the presence of 1,4 µM of non-biotinylated (10x 
TD) (panel c). In detail, 24h after transfection, COS cells were simultaneously incubated with Bio-
TD and 10x oligo or 10x TD for 1 h at 4°C. Cells were then fixed in 4% paraformaldehyde and 
neutralized with NaBH4. Biotinylated TD were detected with streptavidin-FITC (Jackson) and nuclei 
stained with DAPI (Invitrogen). As shown in Figure S8, panel b, the presence of 10x oligo does not 
impair Bio-TD binding to LOX-1 expressing cells. Of note, 10-fold excess of not-biotinylated fully 
assembled TD almost completely abolishes TD binding to LOX-1 (panel c), indicating the specificity 
of the binding.
Figure S6.  Competition assays. LOX-1 transfected COS cells were incubated with 144 nM Bio-TD 
(panel a) in the simultaneous presence of 10-fold excess of a single-stranded oligonucleotide (panel 
b) or non-biotinylated TD (panel c) for 1 h at 4°C. Biotinylated TD were detected with streptavidin-
FITC and nuclei are blue stained with DAPI. Images were obtained with a laser confocal fluorescence 
microscope Olympus FV1000 at 60X magnification and processed by IMARIS software.  Scale bar, 
20 μm.
S9. TD and CM internalization in not-transfected COS cells compared to LOX-1 
transfected cells.
Not expressing (-) and LOX-1 expressing (+) COS cells were incubated with 6 μg/mL of biotinylated 
TD and CM for 1 h at 37 °C. After incubation, cells were lysed, centrifuged and supernatants digested 
with proteinase K for removing the bound proteins that surround the surface of DNS. Samples were 
analyzed by DNA blot. Figure S9 shows the amount of tetrahedral (TD, panel A) and chainmail (CM, 
panel B) internalized by not-transfected (-) compared to LOX-1 transfected COS cells (+). The 
amount of DNS found in not-transfected cells was calculated by densitometric analysis. After 1 h of 
incubation at 37°C, not-transfected COS cells internalize a very low amount of TD and CM that have 
been quantified to be 4.6±0.7 ng/106cells and 8.4±0.9 ng/106cells, respectively. At the same time of 
incubation, LOX-1-expressing COS cells internalize 140 ± 33ng/106cells of TD and 261± 69 ng/106cells 
of CM, confirming that LOX-1-mediated uptake leads to an increase of about 30-fold in the amount 
of internalized DNS.
Figure S7. Representative DNA blots of cell extracts obtained from COS cells expressing (+) or 
not expressing (-) LOX-1 receptor incubated with TD (A) and CM (B). Biotinylated DNS were 
detected with streptavidin-HRP and visualized by enhanced chemiluminescence. 
S10. Stability of non-covalently-linked OD structures in cells.
Non covalently-linked DNS are more unstable in biological fluids. For evaluating their stability inside 
cells, we incubated biotinylated non covalent octahedral nanocages (ncOD) (6 μg/mL) with LOX-1-
transfected COS cells for 3 and 18 h at 37 °C, we purified them from cell lysates and conditioned 
media, treated with proteinase K (100 μg/mL) for 1 h at 37°C and run on 1% agarose gel in TBE 
(Tris-Cl 89 mM pH 8, boric acid 89 mM, EDTA 2mM). A representative DNA blots is shown in 
Figure S10A. Lanes 1 and 4 show the electrophoretic mobility of ncOD before incubation with cells 
(time 0). After 3 h of incubation, intact ncOD structures are barely detectable in cells lysates (lane 2) 
and, after 18 h of incubation, only a smear is visible in cell lysates indicating that the nanostructures 
have been degraded (lane 3). Notably, the analysis of the ncOD in the conditional medium at the same 
time points (lanes 5 and 6), shows that after 18 h the ncOD structures are completely degraded, 
confirming their lower stability, when compared to the covalent DNA nanostructures.
For evaluating whether ncOD undergoes disassembly or degradation at the level of the plasma 
membrane, biotinylated ncOD (6 μg/mL) were incubated with LOX-1-transfected COS cells for 1 h 
at 4 °C, for avoiding cell internalization and analyzing the ncOD bound to the cell surface. Analysis 
of the purified ncOD by DNA blot indicates that, despite the low amount of membrane bound ncOD 
(Figure S10B, lane 2), only a single product is present in the gel with a mobility comparable to the 
input (lane 1), indicating that binding of ncOD to the receptor is not inducing disassembly or 
degradation of the structures. 
Figure S8. LOX-1-mediated uptake of ncOD and their binding to cells. (A) Representative 
DNA blots of lysates and conditioned media from LOX-1-transfected cells incubated with 
biotinylated ncOD for different times at 37 °C, as indicated. (B) Representative DNA blot of lysates 
of LOX-1-transfected cells incubated with biotinylated ncOD for 1 h at 4°C. NcOD were detected 
with streptavidin-HRP.
S11. Stability of SBO structures in cells.
Biotinylated SBO (6 μg/mL) were incubated with LOX-1-transfected COS cells for 1, 3 and 18 h at 
37 °C, treated with proteinase K (100 μg/mL) for 1 h at 37°C and run on 1% agarose gel in TBE 
(Tris-Cl 89 mM pH 8, boric acid 89 mM, EDTA 2mM), supplemented with 6.25 mM MgCl2.
DNA blots were visualized by using streptavidin-HRP. Lane 4 in Figure S11 shows the 
electrophoretic mobility of SBO before incubation with cells (input). Purified SBO, after incubation 
with cells, run with a lower electrophoretic mobility compared to the input (Figure S11, compare 
lanes 1, 2 and lane 3 with lane 4) and a DNA product with a lower molecular weight, corresponding 
to 1 kb, is detected inside cells, as reported for RO (Figure 6, lanes 2, 3 and 4).
Figure S9. LOX-1-mediated uptake of SBO origami in COS cells. Representative DNA blot of 
cell extracts derived from LOX-1-transfected COS cells incubated with biotinylated SBO for 1, 3 and 
18 h at 37 °C. 
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6. Chemo-Enzymatic Preparation of functional click labelled Messenger RNA 
6.1. Prologue  
Nowadays, in vitro transcribed (IVT) messenger RNA (mRNA) has attracted attention as a valid candidate in 
next generation-therapeutics and is considered an asset in treatment of several diseases20. This novel class 
of drugs has already demonstrated feasibility in several areas including vaccination49,50, protein 
replacement74 and cancer therapy21. In the last decades, research groups and especially several companies 
base their own research and business on the development of mRNA therapeutics, including e.g. ModeRNA 
(USA), CureVac, BioNTech (Germany) and AstraZeneca (UK). These companies have gathered tremendous 
attention and were able to raise important fundings for their next development steps20, since this method is 
expected to play a key role in developing and facilitating a future approach to medicine. 
The main idea behind the so-called “mRNA therapy” is to provide IVT mRNA as a carrier of genetic 
information, thus allowing the organism to develop its own cure. For example in vaccination, mRNA coding 
for a specific antigen is used to generate an immune response and lead to the formation of B and T-memory 
cells Figure 11. In the case of protein replacement therapy, mRNA produces the missing protein causing the 
disease. Several advantages have made mRNA more attractive compared to plasmid DNA. Among others, the 
usage of mRNA avoids insertional mutagenesis and potential oncogenesis considering that its activity does 
not require nuclear and genome integration. For this reason, it is also an ideal candidate for protein 





Figure 11: Schematic representation of the usage of mRNA as therapeutic agent, in this particular case in 
vaccination. U.Sahin et al., Nature reviews, 2014, 13, 759-780 
Several groups started to work on chemically modified RNA to expand its chemical properties75,76, but so far 
the biocompatibility of such modification has not been shown. 
Despite the recent advances, there are still some challenges that need to be addressed using IVT mRNA. The 
bio-chemical properties of the RNA render the molecule sensitive towards physical and biochemical 
degradation either in intracellular and extracellular environments. Delivery to a specific target, tissue or 
organ, is still a major challenge for the usage in therapies. To date, mRNA is delivered by liposomal drug 
delivery systems29 , that protect mRNA from degradation in extracellular environments. Anyhow, it was 
observed that lipid nanoparticles are mostly directed and degraded to the liver, that in most of the cases is 
not the final target for the therapy. Furthermore this approach has crucial variations between in vitro and in 
vivo protein expression32. Delivery with lipid nanoparticles containing mRNA has a better expression level in 
cell culture compared to administration in living organisms, while the opposite effect is observed when 
“naked” mRNA is transfected. 
One important discovery to the advancement of mRNA technology was the incorporation of modified bases 
during transcription. The most prominent example is the usage of the N1-methyl-pseudouridine or 
pseudouridine. The replacement of natural uridine with pseudouridine during in vitro transcription, 





The main goal of this project was to develop the cutting-edge technology to enhance the biochemical 
properties of chemically modified mRNA in a cross-disciplinary academia-industry collaboration between the 
LMU München and baseclick GmbH. The technology is based on the incorporation of azide and/or alkyne 
nucleotides during the enzymatic synthesis of the IVT mRNA in order to achieve the modification of the 
resulting molecules post-transcriptionally, making possible to choose among a plethora of modifications 





6.2. Abstract of the publication “Chemo-Enzymatic Preparation of functional click labelled 
Messenger RNA” 
Alkyne and or azide-modified nucleotides are enzymatically incorporated into mRNA and subsequently 
conjugated to fluorescent dyes using click chemistry. This allows visualization of the labelled mRNA inside of 
cells. mRNA coding for the enhanced green fluorescent protein (eGFP) was chosen as a model system and 
the successful expression of eGFP demonstrated that our modified mRNA is accepted by the translation 
machinery. 
6.3. Author contribution  
The author designed the experiments and analyzed the data. Performed all the mRNA preparations,the Hela 
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Chemoenzymatic Preparation of Functional Click-Labeled
Messenger RNA
Stefano Croce,[a, b] Sascha Serdjukow,[a] Thomas Carell,[b] and Thomas Frischmuth*[a]
Introduction
Messenger RNA (mRNA) is the central molecule involved in
transferring the genetic information from DNA into proteins.
Eukaryotic mRNA is usually composed of five different parts : a
5’-CAP,[1–3] a 5’-untranslated region (5’-UTR), an open reading
frame (ORF), a 3’-untranslated region (3’-UTR)[4, 5] and a poly(A)
tail.[6] While the amino acid sequence is encoded in the open
reading frame, the CAP and the poly(A) tail enhance cellular
stability and translation efficiency.[6] The 5’-UTR and 3’-UTR are
often folded in a secondary structure, which provides certain
stability to the mRNA, thus influencing mRNA’s half-life and
turnover rate.[4, 5] To date synthetic mRNAs are prepared enzy-
matically by in vitro transcription from DNA templates,[7] as the
chemical synthesis of long RNAs is still not feasible.
In vitro-transcribed (IVT) mRNA has recently become a prom-
ising candidate for the development of a new class of drugs,[8]
which in principal should allow treatment of all diseases that
require a gain-of-function such as enzyme replacement thera-
py, vaccination, immune response, etc. Due to its transient
properties, mRNA has almost no chance for genome integra-
tion in contrast to DNA based gene-therapy approaches. At
the same time high protein expression levels are often re-
quired. Therefore, the administered mRNA must be sufficiently
stable to allow efficient translation in the target cells.
Preparation of chemically modified mRNA has been one key
element to advance the mRNA technology toward drug devel-
opment. By using various modified nucleotides, the half-life of
the mRNA, the translation efficiency and its immunological
profile are improved. For example, N1-methyl-pseudouridine
results in more efficient translation and at the same time re-
presses innate immune responses in comparison with the un-
modified mRNA.[9]
Apart from incorporation of naturally occurring modified nu-
cleotides, artificial modified nucleotides offer an interesting
option to expand the (chemical) properties of the resulting
mRNA. The seminal work from the groups of Hirao, Benner,
and Romesberg has resulted in several artificial base pairs that
can be replicated and even transcribed into RNA.[10–14] For ex-
ample by using the artificial NaM:TPT3 base pair it was possi-
ble to achieve site-specific RNA labeling. A cyclopropene-modi-
fied TPT3 nucleotide is incorporated by T7 RNA polymerase
during in vitro transcription opposite to the dNaM base in the
DNA template and was subsequently labeled with dye conju-
gates through an inverse electron demand Diels–Alder reac-
tion.[15] More recently, Walunj et al. described an RNA-labeling
method which involves incorporation of 5-iodouridine triphos-
phate (IUTP) by in vitro transcription and subsequent labeling
using a Suzuki–Miyaura cross-coupling reaction.[16] Modification
of mRNA by these artificial nucleotides could profit from in-
creased stability and functionality, but biocompatibility for cells
and the translation machinery are yet unknown.
Herein we present four different methods to modify IVT
mRNA via enzymatic incorporation of alkyne and/or azide-
modified unnatural nucleotides and subsequent labeling using
click chemistry. We were focused on a strategy to chemically
modify IVT mRNA that could modulate properties such as sta-
bility, delivery and tracking but still allows translation into func-
tional proteins. We believe that the establishment of an effec-
Synthetic mRNAs are promising candidates for a new class of
transformative drugs that provide genetic information for pa-
tients’ cells to develop their own cure. One key advancement
to develop so-called druggable mRNAs was the preparation of
chemically modified mRNAs, by replacing standard bases with
modified bases, such as uridine with pseudouridine, which can
ameliorate the immunogenic profile and translation efficiency
of the mRNA. Thus the introduction of modified nucleobases
was the foundation for the clinical use of such mRNAs. Herein
we describe modular and simple methods to chemoenzymati-
cally modify mRNA. Alkyne- and/or azide-modified nucleotides
are enzymatically incorporated into mRNA and subsequently
conjugated to fluorescent dyes using click chemistry. This
allows visualization of the labeled mRNA inside cells. mRNA
coding for the enhanced green fluorescent protein (eGFP) was
chosen as a model system and the successful expression of
eGFP demonstrated that our modified mRNA is accepted by
the translation machinery.
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tive chemo-enzymatic method for modification of still func-
tional IVT mRNA will allow advancement of the current mRNA
therapy development, as chemical modification has already
been demonstrated to be useful for a short interfering (si)RNA
drug,[17] which has been chemically coupled to the sugar N-
acetylgalactosamine for better receptor-mediated uptake.[18]
Results and Discussion
eGFP mRNA model
To establish our mRNA labeling technology, an mRNA encod-
ing for the enhanced green fluorescent protein (eGFP) was se-
lected, because correct translation of the functional protein
can be easily monitored directly via its green fluorescence
properties. The desired mRNA constructs were prepared by in
vitro transcriptions from a linearized DNA template (sequence
in the Supporting Information) containing a T7 promotor, a 5’-
UTR, the eGFP gene, a 3’-UTR composed of two repeats of the
3’-UTR of the b-globin and a 120-mer poly(A) tail. In addition, a
5’-CAP structure was co-transcriptionally introduced by T7 RNA
polymerase using an anti-reverse capping analogue (ARCA). In
this way, the transcription resulted in a stable mRNA including
CAP structure and poly(A) tail, ready for efficient expression in
eukaryotic cells. Chemoenzymatic approaches involving enzy-
matic incorporation of artificial nucleotides and subsequent la-
beling using click reactions[19, 20] have performed well for long
DNA, so it was straightforward for us to adapt them to mRNA.
Incorporation of EUTP during IVT
Our aim was to find a simple method to introduce modifica-
tions at multiple sequence positions of mRNA, which would
first of all enable tracking of mRNA within the cell. Alkyne func-
tional groups were introduced by incorporation of 5-ethynyl-
uridine-trisphosphate (EUTP) using T7 RNA polymerase during
in vitro transcription, Figure 1 A. By replacing all natural uridine
triphosphates with EUTP an mRNA was produced containing
220 alkynes. It was observed that the T7 RNA polymerase in-
corporates alkyne-modified EUTP almost as well as natural UTP,
as similar mRNA yields were obtained for both reactions (<
10 % decrease relative to the natural nucleotides mix). In a first
experiment TAMRA azide was chosen to serve as reporter label
for analysis of the click labeling reaction’s efficiency. Assisted
by the THPTA ligand, the heterogeneous catalyst was pre-acti-
vated and in the presence of an excess of the dye azide the
mixture was incubated at 45 8C for 30 minutes. After reaction
completion, the dye-labeled mRNA was purified using a spin-
column method and then analyzed by agarose gel electropho-
resis. Fluorescence of TAMRA labeled mRNA was clearly recog-
nized in direct comparison with the unclicked alkyne or un-
modified mRNA, Figure 2 B and Figure S1 in the Supporting In-
formation. Due to the modularity of the click reaction, prepara-
tion of several different dye-labeled mRNAs from the same
transcription is possible. To allow optimal tracking of mRNA
inside of cells some of the alkynylated mRNA was reacted with
Eterneon Red azide. Its red fluorescence was ideal for simulta-
neous detection of eGFP fluorescence and dye-labeled mRNA
in HeLa cell culture experiments.
To stress and observe the limit of the labeling technology, at
first an mRNA containing complete replacement of uridine by
EUTP was studied. After 24 h of incubation, bright green fluo-
rescence of eGFP was observed and no visible changes in cell
morphology were detected (Figure S3). This is a good indica-
tion that the alkyne functional group at the nucleobase is well
tolerated, even if it is in the coding region of the mRNA. We
Figure 1. EUTP incorporation. A) Schematic representation of the EUTP incor-
poration into IVT mRNA. B) Unstained (i) and stained (ii) agarose gel contain-
ing linearized plasmid DNA template (lane 2), and its transcription product
(lanes 3–6). The alkyne-containing mRNA (lanes 5–6) was click-labeled
(lanes 5–6) with TAMRA-PEG3-azide, thus fluorescence without staining of
the gel (left, lanes 5–6 B) proves successful click labeling. C) Microscopy
images of HeLa cells transfected with eGFP mRNA labeled with Eterneon
Red fluorescent dye in the 5’-UTR, ORF and 3’-UTR. Left to right: bright field,
green fluorescence, and Cy5 channel. Scale bar : 100 mm.




speculate that the codon-codon interaction with the 5-EU is
similar to natural modifications such as m5C and m6A in
mRNAs.[21, 22] Then, the alkyne functional groups were labeled
with the red fluorescent dye azide. This time eGFP expression
decreased relative to transfected cells with non-labeled control
mRNA (Figure S3). This indicated that due to the high labeling
density the translation at the ribosomes was reduced. There-
fore we decided to partly label the mRNA just replacing 10 %
of the uridine by EUTP during in vitro transcription. In this case
even after the labeling reaction with the fluorescent dye, the
green fluorescence eGFP expression intensity was similar to an
unmodified mRNA expression in transfected cells, but it was
still possible to visualize the presence of the mRNA due to its
fluorescent dye labeling, Figure 1 C.
To prove that the observed eGFP fluorescence was not due
to small amounts of unmodified mRNA (no alkyne, no label)
present in our mRNA preparation with 10 % of EUTP replace-
ment, a transfection experiment was designed where the
amount of unlabeled mRNA was gradually decreased from
100 % (500 ng) to 15 % (75 ng; Table S2). It was observed that
upon reaching 30 % (150 ng) of the unmodified mRNA amount
no eGFP expression was detected using our microscopy setup
(Figure S4). Considering the 220 possible EUTP incorporation
positions and an enzymatic acceptance rate almost like a natu-
ral UTP (as described previously),[23] the probability to produce
unmodified mRNA using 10 % EUTP and 90 % UTP during IVT is
very low. Even assuming lower enzymatic acceptance rates, for
example, 99 % UTP incorporation at each position, only 11 % of
the total mRNAs would result label-free, which is proved to be
insufficient for detect eGFP production in our set-up.
Modification of the poly(A) tail by EATP incorporation
Having been able to introduce alkyne modifications within the
mRNA, we developed a second labeling method, which re-
stricts labeling to the poly(A) tail of the mRNA. The concept
here is based on incorporation of alkyne groups in the poly(A)
tail with 7-ethynyl-7-deazaadenosine 5’-triphosphate (EATP) via
a poly(A) polymerase reaction (Figure 2 A). To determine appro-
priate enzymatic labeling conditions, a short RNA served as a
model system to allow more simple analytical studies and con-
dition screens. A chemically synthetized 31-mer RNA was used
to either incorporate natural ATP or EATP or a mixture of both
by poly(A) polymerase from Escherichia coli. The resulting
product was then analyzed by denaturing polyacrylamide gel
electrophoresis and MALDI-TOF. When only EATP was used, the
RNA was extended by a few nucleotides compared with about
100 nucleotides extension when the natural ATP was present
(Figure S2). By MALDI-TOF the typical spectra of EATP incorpo-
ration is observed with a mass difference of about 350 Da be-
tween adjacent peaks (e.g. , 10 606.7@10 254.9 = 351.8), which
corresponds well to the expected mass difference of 352.2 Da
(C13H13N4O6P) upon EATP incorporation and release of pyro-
phosphate Figure 2 B ii. For incorporation of ATP/EATP mixtures
the mass spectrum gets more complex. An extension by a few
nucleotides was also found for an equimolar mixture of ATP
and EATP, mass differences of 330 (C10H12N5O6P) and 350 Da
can be observed, depending on incorporation of ATP or EATP,
respectively Figure 2 B iii. Also, as the incorporation length in-
creases, peak mixtures and broadening of the peaks are visible,
as the probability for mixed (labeled and unlabeled incorpora-
tion) increases. MALDI-TOF measurements proved successful
incorporation of the EATP nucleotide even when competing
with the natural ATP for enzymatic incorporation. In the next
step, the method was adapted for optimal EATP labeling in IVT
mRNA. After EATP incorporation, the mRNA was labeled with
Eterneon Red azide for tracking in HeLa cell culture experi-
ments. The poly(A) labeling with EATP of the mRNA results in
Figure 2. EATP labeling of the poly(A) tail. A) Schematic representation of
EATP incorporation into the poly(A) tail of IVT mRNA. B) MALDI-TOF results
from E. coli poly(A) polymerase reactions after 30 min incubation using i) no
nucleotide, ii) EATP and iii) EATP/ATP. C) Microscopy images of HeLa cells
transfected with eGFP mRNA labeled with Eterneon Red fluorescent dye in
poly(A) tail. Left to right: bright field, green fluorescence, and Cy5 channel.
Scale bar: 100 mm.




similar eGFP expression as the unmodified mRNA in transfect-
ed cells, Figure 2 C. In our case, the poly(A) labeled mRNA con-
tained a 120-mer unmodified poly(A) tail, followed by a short
part containing a mixture of labeled-alkyne and non-alkyne nu-
cleotides. This way it is reasonable to speculate that the
poly(A) binding proteins have sufficient binding motifs to en-
hance translation, despite the labels.
3’ END modification by AzddATP
To find methods that would allow introduction of azido modifi-
cations in the IVT mRNA several azide-modified nucleotides
were studied for incorporation by T7 RNA polymerase and
poly(A) polymerases. To our delight yeast poly(A) polymerase
was found able to incorporate 3’-azido-2’,3’-dideoxyadenosine
(AzddATP) quantitatively at the end of a short RNA model tem-
plate in just 5–20 min as confirmed by MALDI-TOF measure-
ments. A single new peak at m/z of 10 229.9 was observed for
the sample after azide labeling, with the peak of unlabeled
RNA oligonucleotide (at an m/z of 9898.9) being absent. A
mass shift of about 331 Da was detected which is in accord-
ance with a theoretical calculated mass difference of 338 Da
(Az-ddATP added, C10H11N8O4P) taking the measurement error
of 0.1 % (= 10 Da) into account (Figure 3 B). The lack of subse-
quent peaks (even after prolonged incubation, data not
shown) proved single addition and termination of elongation
by incorporation of 3’-azide-2’,3’-ddATP. The azide labeling con-
ditions were transferred to IVT mRNA (Figure 3 A) and specific
labeling under strain promoted azide–alkyne cycloaddition
(SPAAC) conditions using the DBCO-sulfo-Cy3 resulted in a
singly labeled mRNA.
This mRNA was then used for HeLa cells transfection experi-
ments and similar to the EATP incorporation, the production of
the eGFP was similar to an unmodified mRNA (Figure 3 C).
Dual modification of mRNA
With the ability to modify two different regions of the mRNA
independently, we developed a method to introduce two dif-
ferent modifications on the same mRNA construct. This would
allow in future approaches to label mRNAs with different
chemical entities on one mRNA molecule, for example, ligands
for targeted delivery of the mRNA with labels for tracking or
stabilizing moieties. One approach would be combining our
established labeling methods in a sequential manner (first in-
ternal labeling and click, followed by poly(A) tail labeling and a
second click). In a second and more practical approach we ini-
tially incorporated alkyne modified nucleotides during in vitro
transcription into the mRNA and in a second step azide modi-
fied nucleotides during poly(A)-addition. Combination of
strain-promoted azide–alkyne cycloaddition (SPAAC) followed
by CuI-catalyzed azide–alkyne cycloaddition (CuAAC) enables
dual orthogonal labeling after enzymatic incorporation.[24]
Dual labeled mRNA was generated by combining incorpora-
tion of EUTP during in vitro transcription followed by site-spe-
cific terminal addition of AzddATP Figure 4 A. Such modified
mRNA was initially labeled via reacting the modified mRNA
with DBCO-Cy3 by SPAAC. Because the alkynes inside the
mRNA are not able to react with azides without CuI catalysis,
only specific reaction of the azide with the cyclooctyne modi-
fied dye occurred. Subsequently, the alkynes were clicked to
Eterneon Red azide using the established CuAAC conditions.
The dual labeled mRNA was then transfected in HeLa cells.
In such transfected cells we observed eGFP expression and de-
tected fluorescence of both dyes, the Cy5 analogue (Eterneon
Red) and Cy3 as well (Figure 4 B). This demonstrates that dual
labeling of mRNA is feasible via click chemistry and that such
modified mRNA is still accepted by the translation apparatus,
producing a functional protein.
Figure 3. AzddATP labeling of the poly(A) tail. A) Schematic representation
of the site-specific modification using AzddATP. B) MALDI-TOF analysis of
model RNA oligonucleotide i) before and ii) after yeast poly(A) polymerase
reaction using AzddATP. C) Microscopy images of HeLa cells transfected with
eGFP mRNA labeled with Cy3 fluorescent dye in the poly(A) tail. Left to
right: bright field, green fluorescence, and Cy5 channel. Scale bar: 100 mm.




Quantification of protein expression by FACS
So far, all experiments were analyzed using standard fluores-
cence microscopy imaging. To determine eGFP expression
levels from modified mRNA, a fluorescence-activated cell sort-
ing (FACS) method was established. HeLa cells were transfect-
ed with mRNA and incubated for 24 h, then they were fixed
and analyzed by FACS using two fluorescent channels (green
for eGFP fluorescence, red for dye-labeled mRNA detection) in
correlation to the side scattering (SSC).
When transfected with unmodified eGFP mRNA almost all
the cells with a defined gate P1 equal to 96.5 % were express-
ing the eGFP (Figure 5 B, red population) as compared with
0.5 % of artefactual detection, when no mRNA was transfected
(Figure 5 A). Practically identical eGFP expression levels were
detected for HeLa cells transfected with alkyne modified eGFP
mRNA and a P1 value of 96.4 % (Figure 5 C). This quantification
confirms that the alkyne groups do not change the final pro-
tein amount, which might indicate that they are well tolerated
by the translation apparatus of transfected cells. For HeLa cells
which were transfected with Eterneon Red eGFP labeled
mRNA, a P1 population of 75 % was observed (Figure 5 D),
meaning that even by attaching a sterically demanding dye
molecule to the eGFP mRNA, the ribosomes are still able to
translate the mRNA into a functional protein (75 % compared
with 95 % of unmodified or alkyne modified mRNA). Further-
more, because the mRNA was labeled with the Eterneon Red
dye it was possible to observe the relative mRNA amount
taken up by the cell. Cells that had taken up more mRNA and
thus contained more red fluorescent dye, were also expressing
higher eGFP levels (Figure 5 D), demonstrating how tracking of
transfected mRNA labeled with fluorescent dyes can provide
important information.
Conclusions
In summary, we have developed several methods to produce
chemically modified mRNA in a modular manner by combining
enzymatic incorporation of alkyne and azide modified nucleo-
tides with subsequent labeling via click chemistry. Nucleotide
analogues like 5-ethynyl uridine triphosphate, 7-ethynyl-7-
deaza triphosphate or 3’-azido-2’,3’-dideoxy adenosine have
been found to be well accepted by T7 RNA or poly(A) poly-
merases. The resulting mRNAs were readily functionalized here
with dye molecules. This allows to modify mRNA with bulky
chemical moieties which, when coupled directly to the nucleo-
tide, during enzymatic incorporation would not be accepted.
By varying the amount of nucleotide or choosing the right
enzyme, it is possible to control the labeling density or even
the position. Site selective terminal labeling of mRNA was ach-
ieved by incorporation of an azido nucleotide by yeast poly(A)
polymerase and subsequent SPAAC.
Figure 5. Dot plots of FACS experiments using mRNA-transfected cells after
24 h incubation. eGFP (bottom) and Eterneon Red (top) fluorescence were
studied for A) untransfected cells, B) eGFP mRNA, C) alkyne eGFP mRNA, and
D) Eterneon Red eGFP mRNA transfected cells.
Figure 4. Dual-labeled mRNA preparation. A) Schematic representation of
the dual-labeled mRNA preparation. B) Microscopy images of HeLa cells
transfected with eGFP mRNA labeled with Eterneon Red and Cy3 fluorescent
dyes. Left to right: bright field, green fluorescence, Cy5 and Cy3 channel.
Scale bar: 100 mm.




Furthermore, by combining enzymatic labeling using T7
RNA polymerase and poly(A) polymerase and subsequent click
labeling with SPAAC and CuAAC we were able to produce a
dual modified mRNA molecule. The presented labeling tech-
nique could give access to mRNA based active drugs that can
be chemically engineered to exhibit for example, better stabili-
ty, targeting, tracking etc. or even combine such functions. It
can be speculated that the modification within the sequence,
such as the 5-EU, can alter the formation of secondary and ter-
tiary structures that are important translation regulatory factors
and in this way modulate the protein production and mRNA
half-life.[25] This might have valuable applications for clinical
drug development programs.
Transfection experiments in HeLa cells have shown that the
ribosomal translation machinery can accept several bulky
modifications inside the eGFP mRNA and still produce a func-
tional protein. When quantification of the protein expression
level was performed using FACS, it was observed that the ex-
pression level for alkyne labeled eGFP mRNA are identical to
unmodified eGFP mRNA. Whereas expression of Eterneon Red
labeled eGFP mRNA was slightly decreased, confirming the tol-
erance of the ribosome to the modified mRNA.
Furthermore, it must be pointed out that selecting uridine
as a major modification target could have another benefit,
beyond good T7 RNA polymerase acceptance during IVT pro-
duction. We speculate that because uridine-rich sequences are
known activators of several human RNA sensors,[26, 27] which are
involved in innate immune responses,[28] it is possible that by
modifying uridine immunogenicity of the mRNA will be re-
duced.
Our experiments highlight once again the importance of
click chemistry, which is not just a reaction, able to connect
two molecules, but a sophisticated tool capable of expanding
the chemical space of (bio)molecules, thus enabling new appli-
cations.
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Chemoenzymatic Preparation of Functional Click-Labeled
Messenger RNA






1. Chemicals, Materials and Methods 
Materials and Chemicals 
Chemicals and salts for buffer preparation (e.g. TRIS, etc.) were ordered from Carl Roth, 
Sigma Aldrich or VWR. 
Anti-reverse cap analogue (ARCA), pseudouridine 5’-triphosphate (ΨUTP), EUTP, EATP, 
AzddATP and all unmodified nucleotides were provided by baseclick GmbH. 
T7 RNA polymerase, yeast poly(A) polymerase and DNase I were purchased from Thermo 
Fischer Scientific, E. coli poly(A) polymerase and BspQI were purchased from NEB. 
The fluorescent dye azides were provided by baseclick GmbH, including Eterneon Red azide, 
FAM azide and Tamra azide. Cy3 DBCO was purchased from Jena Bioscence. 
RNase free water (Ultra pure distilled water, DNase & RNase free) was purchased from 
Invitrogen. 
Qiaquick PCR purification and plasmid plus midi purification kits were ordered from Qiagen. 
Methods 
For agarose gel electrophoresis of plasmid, template DNA and RNA transcripts (4.7 kbp and 
1200 mer respectively) 2 % agarose gels (10 x 15 cm) were prepared in 1x TAE buffer (20 mM 
TRIS, 10 mM acetic acid, 0.5 mM EDTA, pH 8.5). 1.5 g agarose (CARL ROTH GmbH, 
Roti®agarose) was dissolved in 75 g 1x TAE buffer in a 250 mL Erlenmeyer flask by 
alternating microwave heating and manual mixing. Loss of water during heating was controlled 
by weighing and replaced if necessary with dH2O. The warm mixture was poured into a planned 
gel cast equipped with either a 15 or 20 sample comb. Samples were prepared with 20 % 
purple loading dye (NEB), 2-log DNA ladder (0.1-10 kbp, NEB, N3200) was prepared 
accordingly, usually 0.5 µL marker were used in 5 µL loading volume. Gels were run in 1x TAE 
buffer applying constant power (10 W, max. 500 V, max. 100 mA) for 60 min. Then, gels were 
incubated in a freshly prepared 1:10 000 ethidium bromide dilution for 15 min and then 
destained in dH2O for 15 min. For visualization a Gel Doc EZ Imager (BIO RAD) was used. 
For polyacrylamide gel electrophoresis of RNA (31 mer) 7 % polyacrylamide gels (8.6 x 6.7 
cm) were prepared in 1x TBE buffer (0.1 M TRIS, 0.1 M boric acid, 2 mM EDTA, pH 8.3) and 
7 M urea (Sigma Aldrich). 3.7 mL of polyacrylamide 30 % (Sigma Aldrich) and 6.7 g of urea 
were dissolved in a final volume of 16 mL of TBE 1x, 10 µL of tetramethylethyleneamine 
(TEMED Sigma Aldrich) and 100 µL of ammonium persulfate (APS) 10 % (VWR) freshly 
prepared were added for polymerization. The mixture was poured into a gel cast (BIO RAD) 
equipped with a 10 sample comb. Samples were prepared with 20 % Purple loading dye 
(NEB), low molecular weight ladder (25-766 bp, NEB, N3234) was prepared accordingly. The 
samples were heated 5 min at 90 °C before loading. Gels were run in TBE buffer 1x at 100 V 
(constant) for 60 min. Then, gels were incubated in a freshly prepared 1:10 000 ethidium 
bromide dilution for 15 min and then destained in dH2O for 15 min. For visualization a Gel Doc 
EZ Imager (BIO RAD) was used. 
Purifications of plasmid DNA was done using the plasmid plus midi kit according to 
manufacturer’s instructions. Purification of IVT mRNA was done using the PCR purification 
kit following manufacturer’s recommendations for PCR fragments with one exception: RNase 




HeLA cells were cultured at 37 °C, 5 % CO₂ and 95 % humidity in Dulbecco’s modified 
Eagle’s medium (DMEM) supplemented with 10 % heat-inactivated fetal bovine serum (FBS, 
Gibco), 2 mM L-glutamine, 100 U/mL penicillin and 100 μg/mL streptomycin, Sigma Aldrich. 
Cell experiments were performed in a µ-Slide plates (Ibidi®). 
Transfection of mRNA was done using the mRNA transfection kit from baseclick GmbH 
following manufacturer’s instructions, 0.5 µg of mRNA was applied to 25,000 HeLa cells (CLS 
GmbH) reaching confluence. The cells were incubated at 37 °C for 24 hours before analysis 
under the fluorescent microscope, GFP filter: (470/22 excitation; 510/42 emission), Cy5 filter 
(628/40 excitation; 692/40 emission) and Cy3 filter (531/40 nm excitation; 593/40 nm emission) 
were used for detection. 
Matrix-assisted laser desorption/ionization-time-of-light (MALDI-TOF) mass spectra were 
recorded on a BRUKER AUTOFLEX II. For MALDI-TOF measurements analysis of short 
oligonucleotides the samples were dialyzed on a 0.025 µm VSWP filter (Merk Millipore) against 
ddH2O for 2 h, then co-crystallized in 3-hydroxypicolinic matrix (HPA: 25 mg 3-hydroxypicolinic 
acid, 5 mg ammonium citrate, 5 μL 15-crown-5 in 0.5 mL H2O/MeCN = 1:1). 
Microscopy of mRNA transfected cells. HeLa cells were imaged on a µ-slide from Ibidi® 
using EVOS FL cell imaging system equipped with the GFP EVOS light cube (470/22 nm 
excitation; 510/42 nm emission), RFP EVOS light cube (531/40 nm excitation; 593/40 nm 
emission) and Cy5 EVOS light cube (628/40 nm excitation; 692/40 nm emission).  
FACS. HeLa cells flow cytometer data were obtained using the BD FACS Canto II equipped 
with air cooled green (488 nm solid state; 20 mW laser output) and red (633 nm HeNe; 17 W 
output) lasers, and the data were analyzed with the FACS Diva software. The fluorescent 
detectors/filters relevant for this study were FITC (530 +/- 30 nm) and APC (660 +/- 30 nm), 
respectively. The cells were detached from the flask immediately before analysis and the 
samples were kept in buffer during acquisition, with a flow rate of 10 µL/min. FSC and SSC 
were used for detection of forward light scatter parameter and side light scatter parameter. The 
machine was cleaned before and after each measurement. The photomultiplier tube (PMT) 
voltage for each parameter was adjusted in order to have the cells displayed in the center of 
the investigating plot. 
2. DNA Template Preparation 
The plasmid containing the eGFP gene mRNA under control of a T7 promotor was a generous 
gift from the research group of Prof. Rädler (LMU München). About 100 ng plasmid were 
transformed into 5-alpha Escherichia coli cells (NEB) according to manufacturer’s 
recommendations and then used to inoculate 20 mL LB medium (10 g/L tryptone, 5 g/L yeast 
extract, 10 g/L NaCl) containing 50 µg/mL kanamycin as a selection marker. This was 
incubated overnight at 37 °C, 200 rpm before the cells were harvested by centrifugation 
(13,000 rpm 15 min, 4 °C). The plasmid was isolated using the plasmid plus midi purification 
kit (QIAGEN) according to manufacturer’s instructions. Usually this yielded 50-60 µg of plasmid 
DNA, which was linearized using BspQ1 restriction enzyme (NEB) according to manufacturer’s 
recommendations. This results in a linear DNA template that ends directly after a 120 mer poly 
A tail coding sequence. Purity of the DNA template was assessed by nanophotometer 





3. In vitro Transcription Reactions 
In a 50 µL final reaction volume 20 units of T7 RNA polymerase (THERMO FISHER), 1 µg of 
template DNA and several nucleotides (Supporting Table 1) were combined in transcription 
buffer (40 mM Tris-HCl, pH 7.9, 6 mM MgCl2, 4 mM spermidine, 10 mM DTT). 
In order to generate differently labeled mRNA molecules, different mixtures of nucleotides were 
generated and used for the mRNA synthesis as listed below as final concentrations 
(Supporting Table 1). One mixture was used to produce unmodified mRNA (mixture A), one 
was used for the EUTP modified mRNA (mixture B) and the other one for the dye labeled 
mRNA (mixture C). 
Supporting Table 1. Final concentrations of nucleotide mixtures used for the production of 
(modified) mRNAs. 














A 4.00 1.50 1.25 1.00 1.25 1.25 - 
B 4.00 1.50 1.25 1.00 - 1.25 1.25 
C 4.00 1.50 1.25 1.00 0.63 0.63 0.63 
 
Transcription reactions were incubated for 2 hours at 37 °C and then 2 units of DNAse I 
(THERMO FISHER) were added and incubated for 15 minutes at 37 °C to digest the DNA 
template and make its removal easier. The mRNA was purified by a spin column method 
according to manufacturer’s instruction (QIAGEN). When click labeling was performed (e.g. for 
nucleotide mixture C), 2 µg of purified alkyne mRNA, 1 nmol e.g. Eterneon Red 645 Azide 
(baseclick GmbH), a single reactor pellet and 0.7 µL 10x Activator² (baseclick GmbH, Oligo² 
Click Kit) were combined in a total reaction volume of 7 µL. The reaction mixture was incubated 
at 45 °C for 30 min and then cleaned using a spin column method according to manufacturer’s 
instruction (QIAGEN). 
4. Gel Analysis of Plasmid and Modified mRNA 
The plasmid and its linearized form were prepared according to section 2, the mRNA was 
prepared according to section 3 with minor exceptions and then analyzed by agarose gel 
electrophoresis. The nucleotide mixture used for these in vitro transcription experiments was 
1.25 mM EUTP/GTP/CTP and 1.5 mM ATP and click reactions were performed using either 
FAM azide or TAMRA azide (baseclick GmbH). In order to find the best incubation duration for 
the CuAAC reaction conditions a time course with 5, 10, 20, 30 and 45 minutes at 45 °C was 
done and directly detected via the TAMRA label fluorescence (Supporting Figure 1 lane 7-11). 
Unlabeled oligonucleotides were detected after ethidium bromide staining (Supporting Figure 
1, lane 1-4, 6).  
It was found that after 45 min TAMRA labeling (Supporting Figure 1, lane 11) is most efficient, 
but a decrease in RNA amount (Supporting Figure 1, lane 7-11, EtBr) indicated incompatibility 
for our protocol with higher labeling rates. We established 30 min incubation as a compromise 
between labeling rate and RNA recovery. FAM-azide labeling (Supporting Figure 1, lane 5) 




a 30 mer oligonucleotide azide (baseclick GmbH), not relevant for the purpose of this 
manuscript. 
 
Supporting Figure 1. 2 % agarose gel of plasmid, linearized plasmid and mRNA from IVT and click reactions. 
5. General Production of Alkyne-Labeled mRNA using EATP 
mRNA was produced according to section 3 and Supporting Table 1 A. Then in a 20 µL 
reaction volume 5 units of Escherichia coli poly(A) polymerase, 6 µg of mRNA and nucleotides 
(EATP and ATP 2mM final concentration each) were combined in reaction buffer (250 mM 
NaCl, 50 mM Tris-HCl, 10 mM MgCl2, pH 7.9). The mixtures were incubated for 30 minutes at 
37 °C or for 1 hour at 37 °C. The mRNA was purified by a spin column method according to 
manufacturer’s instruction (Qiagen). The click reaction was done according to section 3. 
6. Model System Study for Poly(A) Labeling 
In order to prove incorporation of the EATP within the poly(A) tail a short RNA oligonucleotide 
(31 mer, CUAGUGCAGUACAUGUAAUCGACCAGAUCAA) was used as template for the 
poly(A) polymerase reaction using final concentrations of: 
A) 1 mM ATP 
B) 1 mM EATP; 
C) 0.5 mM ATP and 0.5 mM EATP. 
In a 20 µL reaction volume 5 units of Escherichia coli poly(A) polymerase, 2 µg of RNA (31 
mer) and nucleotides (final concentration of A-C) were combined in reaction buffer (250 mM 
Tamra and FAM signal EtBr staining










NaCl, 50 mM Tris-HCl, 10 mM MgCl2, pH 7.9). The mixtures were incubated for 30 minutes at 
37 °C or for 16 hours at 37 °C. 
The results were analyzed by denaturing polyacrylamide gel electrophoresis. Compared to the 
template RNA oligonucleotide (Supporting Figure 2, Lane 2) a band or smear at higher 
molecular weight appeared for all samples, which were incubated in the presence of the 
poly(A) polymerase using different nucleotides and incubation durations (Supporting Figure 2, 
Lane 3-7). This indicated successful incorporation of ATP or its alkyne analog EATP. Within 
30 min incubation the incorporation of ATP (Supporting Figure 2, Lane 3) was more efficient 
compared to EATP (Supporting Figure 2, Lane 4) or a mixture of EATP and ATP (Supporting 
Figure 2, Lane 5). By extending the incubation time for the incorporation of EATP to 16 h, the 
length of the poly-EA-addition was increased (Supporting Figure 2, Lane 6) in comparison to 
30 min incubation (Supporting Figure 2, Lane 4). Interestingly, for the nucleotide mixture 
containing ATP and EATP no change was observed after 16 h (Supporting Figure 2, Lane 7) 
compared to 30 min. 
 
Supporting Figure 2. Stained 7 % denaturing polyacrylamide gel with samples from poly(A) addition experiments 
using ATP or EATP in different conditions. 
7. Site-Specific Azide Labeling in mRNA 
mRNA was produced according to section 3 and nucleotides as in Supporting Table 1 A. Then 




2´,3´-ddATP (0.5 mM final concentration) were combined in reaction buffer (20 mM Tris-HCl, 
pH 7.0, 0.6 mM MnCl2, 20 µM EDTA, 200 µM DTT, 10 µg/mL acetylated BSA, 10 % glycerol). 
The mixture was incubated for 20 minutes at 37 °C. mRNA was purified by a spin column 
method according to manufacturer’s instruction (Qiagen). When click labeling was performed, 
5 µg of purified azide mRNA, 2 nmol DBCO-Sulfo-Cy3 (Jena Bioscence), were combined in a 
total reaction volume of 30 µL. The reaction mixture was incubated at room temperature 
overnight and then cleaned using a spin column method according to manufacturer’s 
instruction (Qiagen). 
8. Model System Study for Azide Labeling 
In order to prove incorporation of the 3´-Azido-2´,3´-ddATP at the end of the poly(A) tail a short 
RNA oligonucleotide (31 mer, CUAGUGCAGUACAUGUAAUCGACCAGAUCAA) was used as 
model template for the poly(A) polymerase reaction using: 
In 20 µL reaction volume 20 pmol of RNA oligonucleotide, 500 µM 3´-Azido-2´,3´-ddATP, 
600 U of yeast poly(A) polymerase were mixed in buffer (25mM Tris-HCl (pH 7.0), 40 mM KCl, 
0.5 mM MnCl2, 50 µM EDTA, 0.5 mM DTT, 0.2 mg/mL BSA, 10 % glycerol) and were 
incubated for 5 minutes at 37 °C. 
9. Sequence of the eGFP DNA Template and Map of the Plasmid 
This is the DNA sequence (5’ to 3’ direction) necessary for the production of the mRNA that 
was used in this study. Sequence parts are highlighted in various colors: The T7 promotor in 



























Supporting Figure 3: Map of the plasmid pSTI-A120 used for the production of the eGFP mRNA via T7 RNA 
polymerase reaction. It contains a T7 promotor (orange), a ribosome binding site (RBS, violet), the eGFP coding 
sequence (EGFP, green), two times the -globin UTR (grey) and PolyA sequence (red) followed by a BspQ1 
restriction site for convenient IVT from linearized plasmids. 
10. Additional Cell Culture Experiments 
100 % EUTP Replacement 
In this experiment the mRNA was prepared according to section 3 and nucleotides as in 
Supporting Table 1 B. When labeling was required the click reaction was done according to 
section 3 using Eterneon Red Azide (baseclick). Cell culture, transfection and fluorescence 





Supporting Figure 4: Microscopy images of HeLa cells, which have been transfected with mRNAs containing A) no 
natural uridine (but 5-ethynyl uridine instead) and B) the mRNA as in A) after click to Eterneon Red-azide. In B) it 
is visible how by replacing all the natural uridine with an ethynyl derivative and click labelling the translation 
efficiency has been reduced, but the ribosomes are still able to produce active protein. Scale bar is 100 µm and 
both pictures were taken with 120 ms exposure time.  
Decreasing Amount of mRNA 
In order to find out whether the signal of the green fluorescent protein (eGFP) is due to the 
small fraction of mRNA that did not incorporate the EUTP, transfections using decreasing 
amounts of unmodified eGFP mRNA were performed. The amount of mRNA coding for the 
eGFP was gradually decreased according to Supporting Table 2 and the missing material was 
replaced with an inactive RNA. The unmodified eGFP mRNA for this study was produced 
according to section 3 and nucleotides as in Supporting Table 1 A. 
Supporting Table 2: Decreasing amount of unmodified eGFP mRNA used for transfection in cell culture 
experiments. 
 100 % 50 % 40 % 30 % 20 % 15 % 
eGFP 
mRNA  
500 ng 250 ng 200 ng 150 ng 100 ng 75 ng 
Inactive 
RNA  












Supporting Figure 5: Microscopy images showing the eGFP signal 24 h after transfection of different mRNA 
amounts compared to the standard amount (100 %). Scale bar is 100 µm and all pictures were taken with 60 ms 
exposure time. 
As visible from Supporting Figure 5 by decreasing the amount of mRNA, the signal of the eGFP 
decreases at the same time. Reaching 30 % of the original mRNA amount the signal of the 
fluorescent protein is hardly visible. In this experiment we successfully proved that the active 
protein is not produced from the small fraction of mRNA that did not incorporate the EUTP. 
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7. Super-sensitive multi-fluorophore RNA-FISH using click chemistry  
7.1. Prologue 
In situ hybridization is a cytogenetic technique that allows researchers to visualize and map genetic material 
in single cells, e.g. entire chromosomes, specific gene or portion of it37,79 in animals and plants. Thus it can be 
used to diagnose a variety of chromosomal abnormalities (monosomy and trisomy), re-arrangements such 
as translocations, microdeletions and duplication by clinicians. The technique is based on probe consisting of 
ssDNA bearing a tag, designed and synthesized in order to hybridize with part of genomic DNA with a high 
degree of complementarity. Since its first appearance, that involved radioactive probes, (Gall & Pardue, 
1969)80, different variations have been developed with an enormous increase in sensitivity, nowadays using 
fluorescent tags. 
Theoretically, fluorescent in situ hybridization (FISH) is a very simple assay, it is based on the ability of probes 
to hybridized with their complementary sequence of a chromosome previously fixed on a slide for 
microscopy. When the probes already contain fluorescent tags, after hybridization the position can be 
detected directly using a fluorescent microscope, Figure 12. When the probes do not contain a fluorescent 
tag, but haptens or biotin, a following step for fluorescent labelling is required, e.g using an antibody bearing 
a fluorophore and binding to the hapten.  
Since the late 1990 (Femino et.al 1998)81 FISH is not only restricted to DNA or chromosomal analysis but also 
to RNA detection such as expression of specific alleles, viral infections or mRNA distribution.  
 
Figure 12: Mitotic chromosomes of rye (Secale cereal) hybridized with centromere-specific repeat Bilby fluorescent 
probes. M.Said et al., The Plant Genome, 2018, 12, 1-13. 
The fluorescent probes can be prepared with different methods such as nick translation, random priming, 
PCR and end labelling. By nick translation is intended a method for the preparation of the probes where 
deoxyribonuclease I (DNase I) creates “nicks” in the DNA, leaving a 3’ hydroxyl group used then by DNA 




denatured before the assay takes place. In random priming, small random oligonucleotides, usually between 
6 and 9 nt long, are used to anneal to a denatured DNA fragment and then with the usage of the Klenow 
fragment polymerase, the oligonucleotides are extended, thereby incorporating fluorescent nucleotides, 
resulting in a uniformly labelled dsDNA. PCR is mostly used for the preparation of labelled versions of 
chromosomal regions, where the preparation of very long labelled probes is based on the ability of DNA 
polymerase to introduce labelled nucleotides during the polymerase cycles. End-labelling can be divided in 
5’ end labelling or 3’ end labelling. The first one uses the activity of the T4 polynucleotide kinase to introduce 
phosphate groups which can then be conjugated to fluorescent labels. The second one uses the ability of the 
terminal deoxynucleotidyl transferase (TdT) to introduce labelled dideoxynucleotides triphosphates82,83. 
Nowdays also the use of NHS chemistry is one of the most preferred methods for the preparation of 
fluorescent probes, where an amino group at the 3’ end introduced during solid phase synthesis of the 
oligonucleotide, then reacted with an NHS-ester on a fluorophore. 
As obvious consequence, probe-labelling is a critical part of the total assay, that still needs to be optimized 
and ameliorated. Therefore we propose here a method for the labelling of FISH probes based on click 
chemistry. Click chemistry has proven to be a very efficient method that allows the production of probes 
bearing not only one label but several of them. The production of probes with an increased fluorescence can 
even allow the detection of the target by flow cytometry, as proven by this work where the expression of 
specific mRNA was detected in a mixed cells population, furthermore we could prove that the so prepared 
probes are even able to detect virus infections by the detection of viral mRNA, often folded in secondary 
structures and difficult to be detected by other traditional methods. In particular FACS detection can be of 
fundamental importance in clinical studies where the detection is still done using fluorescent microscopy by 
long and tedious work of the clinicians, thus speeding up the analysis and reducing their costs. 
7.2. Abstract of the publication “Super-sensitive multi-fluorophore RNA-FISH using click 
chemistry” 
The reliable detection of transcription events via the quantification of the corresponding mRNA is of 
paramount importance for the diagnostics of infections and diseases. The quantification and localization of 
the mRNA of a particular gene allows characterizing disease states more directly compared to an analysis on 
the DNA level. This is particularly needed for the early detection of virus infections as now required for Corona 
diagnostic. In situ mRNA analysis, however, is a formidable challenge and currently performed with sets of 
single-fluorophore containing oligonucleotide probes that hybridize to the mRNA at question. Often a large 
number of probe strands (often >30) are required to get a reliable signal. The more oligonucleotide probes 
are however used, the higher are potential off-target binding effects that create background noise. Here, we 
used click chemistry and alkyne modified DNA oligonucleotides for preparing multiple-fluorophore mRNA 




a very small number (5-10) of probe strands. The new method is so sensitive that it even enabled the in situ 
detection of viral transcripts just 4 hours after infection. 
7.3. Author contribution 
The Author planned and executed the FACS experiments, prepared the click probes and did the HPLC analisys 
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Supersensitive Multifluorophore RNA-FISH for Early Virus
Detection and Flow-FISH by Using Click Chemistry
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The reliable detection of transcription events through the
quantification of the corresponding mRNA is of paramount
importance for the diagnostics of infections and diseases. The
quantification and localization analysis of the transcripts of a
particular gene allows disease states to be characterized more
directly compared to an analysis on the transcriptome wide
level. This is particularly needed for the early detection of virus
infections as now required for emergent viral diseases, e. g.
Covid-19. In situ mRNA analysis, however, is a formidable
challenge and currently performed with sets of single-fluoro-
phore-containing oligonucleotide probes that hybridize to the
mRNA in question. Often a large number of probe strands (>
30) are required to get a reliable signal. The more oligonucleo-
tide probes are used, however, the higher the potential off-
target binding effects that create background noise. Here, we
used click chemistry and alkyne-modified DNA oligonucleotides
to prepare multiple-fluorophore-containing probes. We found
that these multiple-dye probes allow reliable detection and
direct visualization of mRNA with only a very small number (5–
10) of probe strands. The new method enabled the in situ
detection of viral transcripts as early as 4 hours after infection.
Introduction
Gene expression varies significantly between individual cells
and it is strongly altered in disease states. Viral infections for
example lead to early transcription of virus-specific genes that
could be exploited for an early diagnosis and characterization
of the infection. In general, basically all malfunctioning
processes in cells induce transcriptional changes.[1,2] These go in
hand with altered levels of messenger RNAs (mRNAs). In
extreme cases disease related mRNA may not be present at all
in the normal state. In most cases however, the levels of specific
mRNA will be changed, which requires reliable methods to
quantify mRNA transcripts. Detection and quantification of a
specific mRNA is thus highly desirable from a diagnostic point
of view. Particularly informative are methods that allow the
quantification of mRNA levels with spatial resolution. Currently,
however, intracellular localization and quantification of mRNA
faces a number of challenges that hinder routine use. The most
common way to detect mRNA (or other RNAs) in cells is
fluorescence in situ hybridization (RNA-FISH).[3] The method
reveals localization patterns of individual RNA transcripts in cells
or tissues and as such, RNA-FISH is the method of choice for
quantitative single-cell transcriptomic studies.[4–8] The currently
available technology behind RNA-FISH technologies is based on
multiple (up to 50) individual anti-sense single-stranded (ss)
DNA probes, which are approximately 22 nucleotides long. Each
probe oligonucleotide carries a single fluorophore, which is
typically introduced as its activated NHS ester to an amino
group present at the 3’-end of the probe.[4,5] The pooled
fluorescent ssDNA probes are finally added to fixed and
permeabilized cells for hybridization with the target RNA. The
large number of probe strands in such experiments is needed
to create a sufficiently strong fluorescence signal. However,
generally the larger the number of probe oligonucleotides that
are used, the larger is often also off-target staining, which
obscures the signal-to-noise ratio. A solution to the problem is
deconvolution software that is able to increase the specific
signal.[9] From a chemical point of view reduction of the number
of probe strands is desirable and this has led to efforts to
modify the probe oligonucleotides with, for example, LNA to
increase binding. Importantly, mRNA analysis based on flow-
cytometry is so far very challenging with contemporary RNA-
FISH.
Here we report a small FISH-probe set for mRNA, where
every probe contains three fluorophores instead of just one.
These multichromophore probes were conveniently prepared
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using the CuI-catalyzed azide-alkyne click reaction.[10–19] In order
to avoid stacking of the fluorophores on top of each other,
which might induce self-quenching, we chose a fluorophores
with two additional sulfonate groups, which provide two
negative charges per fluorophore. This is supposed to minimize
the interaction with the fluorophores with each other and with
the negatively charged DNA. Indeed, with this design a small
number of probe strands (5–10) was found to be sufficient for
the visualization of RNA transcripts. The new probes design
allowed not only transcript quantification and localization by
microscopy, but it also enabled transcript analysis using flow-
cytometry.
Results and Discussion
The new procedure based on click chemistry is illustrated in
Figure 1. As a test-system for the mRNA-FISH we used a
HEK293T cell line transfected with a plasmid containing the
gene coding for the enhanced green fluorescent protein (eGFP).
We synthesized ten DNA probe oligonucleotides targeting
specific areas of the eGFP-mRNA transcript, with each one
containing 22 nucleotides (Figure S1 in the Supporting Informa-
tion). Into each of the ten DNA probe strands we inserted three
C8-alkyne-dU building blocks at former dT positions (Figure 1
and Table S1) using phosphoramidites that we had developed
previously.[20] The ten triple-alkyne DNA probes were finally
purified by HPLC and individually subjected to a click reaction
with Eterneon-Red 645 azide (cyanine-5 analogue). The so
obtained three Eterneon containing DNA probes (10×3) were
finally purified by a simple ethanol precipitation. Due to the
high efficiency of the click reaction, no further HPLC purification
of the probes was required. For the probes prepared for the
virus experiment (vide infra) we also confirmed the purity of the
obtained probe strand by HPL chromatography (example
shown in Figure S2). HPL chromatographic analysis of our 10×3
probe set proved good absorption and fluorescence properties
(Figures S3 and S4).
In order to compare the obtained data with the state-of-
the-art we performed in parallel studies with a commercially
available RNA-FISH probe set. The provider suggested for the
requested detection a set of 30 probe oligonucleotides
(Table S2) each one carrying one Quasar 670 fluorophore. The
purchased oligonucleotide probes are shown in Figure S1.
In order to investigate the ability to detect RNA, we first
performed in vitro experiments with isolated total-RNA obtained
from wild-type HEK293T and HEK293T-eGFP, stably expressing
the eGFP gene. The data are depicted in Figure S5, we obtained
clearly visible spots with the (10×3) triple modified probes.
Importantly, the 10×3 set provided bright spots even without
the use of the special deconvolution software. In order to
exclude that the high spot density obtained with the new
probes is caused by unspecific binding, we performed a
negative control with total RNA isolated from HEK293T cells not
expressing the eGFP-protein (control probes). Here, as expected
far fewer spots were obtained, which rules out this possibility.
After these in vitro experiments, we next investigated the
properties of the 10×3 probe set in fixed cells (Figure 2). To this
end, the HEK293T cells were grown on 8-well μ-Slide (ibidi) and
transfected with a plasmid DNA containing a gene coding for
eGFP. The cells were fixed and permeabilized using the
standard protocols (see Materials in the Supporting Informa-
tion). We next added the mixture containing our 10×3 probe
set and as a positive control, we also performed an experiment
with the 30×1 set. Both probe sets were incubated over night
at 37 °C. After washing, we analyzed the cells by fluorescence
microscopy. The result of the study is shown in Figure 2a. In
order to quantify the background fluorescence signal, we
calculated the signal intensity obtained after in situ hybrid-
ization of the probe sets lacking the eGFP-locus. This back-
ground signals for the 10×3 and 30×1 experiment were
Figure 1. Depiction of RNA-FISH and schematic representation of the probe
synthesis. a) Synthetic oligonucleotides with C8-alkyne-dU modifications in
various positions were individually conjugated with a fluorescent dye azide.
After reaction, the oligonucleotides were mixed to a probe set. b) The probe
set was hybridized to the mRNA. After in situ hybridization, the mRNA
molecules can be detected by flow-cytometry and/or microscopy. c)
Depiction of the probes labeled with click chemistry hybridized to the target
mRNA.
Figure 2.mRNA of eGFP-expressing HEK cells labeled with 10×3 and with
30×1 probe sets. a) FISH microscopy images of the 10×3 and 30×1 set of
probes (scale bar: 10 μm) b) Comparison of the signal and background
intensities. c) Signal and background obtained with CuAAC-labeled probes
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subtracted from 10×3 and 30×1 data sets obtained with the
eGFP expressing cells (Figure 2b). As depicted in Figure 2a we
saw for the 10×3 probe set diffraction-limited spots were
detected showing clearly the presence of the complementary
mRNAs (Figure 2a, red channel). The signal-to-noise ratio was
strongly increased. A small caveat is that we noted a slightly
increased background signal with the 10×3 probe set (Fig-
ure 2b, dark gray bar) likely because the oligonucleotide
containing three dyes are more hydrophobic, which may give
slightly increased unspecific binding, which increases the back-
ground. This effect is obviously overcompensated by the strong
increase of the fluorescence signal obtained from specific
binding events.
We next experimented with different number of probe
strands and dye loading and found that the most reproducible
data were indeed obtained with ten oligonucleotide probe
strands containing each three fluorophores. In our hands this
probe design provided in all investigated cases the best signal-
to-noise ratios (Figures 2c and S6).
We next investigated if we could further reduce the
background signal when we performed the click reaction after
in situ hybridization as shown in (Figure S7). For this study, we
used a set of 10 probe strands with 3 alkyne units, hybridized
them with the cellular mRNA and performed the CuAAC-
reaction subsequently in situ with a TAMRA azide. While the
signal-to-noise ratio indeed improved, we noted that we had to
perform extensive washing in order to remove additional dye,
which is typically used in large excess. This makes this
procedure a little more accurate but cumbersome to perform.
We next investigated if the performance of the 10×3 probe
design allows to detect mRNA even using flow-cytometry in a
mixed cell population. For the experiment, we mixed HEK293T
cells with and without eGFP-expression in a ratio 20 :1
(95% HEK293T+5% HEK293T-eGFP). Then, flow-cytometric
measurements of the mixed cell populations were performed at
λex=488 nm/λem=530 nm for the detection of the eGFP
protein. The correct ratio of the mixed cell population was
nicely reproduced (Figure 3a). We then used the flow-FISH
protocol described by Arrigucci et al.,[21] which involves trypsini-
zation and resuspension of cells. The cells in suspension were
permeabilized, fixed and subsequently incubated with the
probe sets. Again, we performed the study with the new 10×3
set in comparison to a classical 30×1 design. When we
measured at λex=633 nm/λem=660 nm, which is suitable for
both the Eterneon-Red 645 azide and the Quasar 670 dye, in
the absence of hybridized probes, a single population was
observed (Figure S8i). The upper plot of Figure 3b shows the
hybridization experiment using the classical probe set at
0.05 ng/μL. Here, only a single population containing both GFP-
positive and GFP-negative cells was detected at 660 nm. When
the 10×3 probe set was used however at the same concen-
tration (lower plot), the GFP-positive population nicely sepa-
rated from the GFP-negative cells. When the separated
population was gated (in blue), the exact proportion of cells
expressing the eGFP was observed for the two different
detection wavelengths. The same result with the classical 30×1
probe set was only obtained, when the concentration was
increased fourfold to 0.2 ngDNA/μL (Figure S8ii). These flow-
FISH data show again that the 10×3 probe allows to perform
flow-FISH. Although an exact comparison between the 10×3
and the 30×1 probe sets is not possible, because of the
differences in the fluorophore, the connectivity of the fluoro-
phore to the probe and the quality of the strands, we believe
that the data support the idea that flow-FISH is possible with
our new probe design that has a limited number of probe
oligonucleotides each one carrying three fluorophores.
In order to show that the new probe oligonucleotides are
able to report transcription of a relevant endogenous gene by
flow-cytometry, we next tested if the above method would be
suitable for the detection of the ABL1-transcript. This time, we
used a slightly larger 15×3 probe set. In order to again obtain
comparative information we compared our design with a
reported detection that used in this case 48 single labelled
oligonucleotides (Semrau et al.).[5] The results are depicted in
Figure 3c. While the 15×3 probe set with only 0.05 ngDNA/μL
provides a clear shift in fluorescence compared to the negative
control, the 48×1 probe set was under these conditions unable
to provide a specific signal separation at this concentration.
We finally explored if the new (10×3) probe design enables
imaging of RNA targets that are hard to image with conven-
tional FISH probes. Such targets are characterized by extensive
secondary structures that provides only few accessible sites for
probe hybridization. We tested our probes by targeting a ~1 kb
RNA viral transcript of the rotavirus A (RVA) gene segment-7.
The idea was to test whether our set of probes detects these
transcripts shortly after virus infection when the concentration
of the transcript is expected to be very low. This specific target
was chosen because of its extensive secondary structure that
precludes hybridization of multiple probes, posing additional
Figure 3. Flow cytometry analysis of mixed HEK293T and HEK293T express-
ing eGFP in a ratio 20 :1. a) Mixing ratio determined on the basis of eGFP
fluorescence. b) Mixing ratio determined by flow-FISH. At 0.05 ng/μL of
probe, separation was only possible for the 10×3 set and establishes the
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challenges for conventional FISH.[22] We fixed rotavirus-infected
cells, 4 hours post infection and incubated them with the (10×
3) DNA probe set targeting the RNA regions that were predicted
to have less pronounced secondary structures.[23] To facilitate
the detection of virus-infected cells, we took advantage of a
stable cell line that expresses the rotavirus non-structural
protein (NSP5)[24] fused to eGFP (see Methods in the Supporting
Information).
After 4 hours post infection RVA, transcripts could be readily
detected (Figure 4, top panel, red signal). No transcript specific
signal was observed in mock-infected cells (Figure 4, bottom
panel).
In parallel, we also analyzed eGFP-NSP5-marked foci in RVA-
infected cells to identify cells at a more advanced stage of
infection (Figure 4, top panel, green signal). As expected, these
cells showed higher levels of the RNA transcript fully consistent
with an increase of the amount of viral RNA transcripts over the
course of the viral infection.
Importantly, the increased sensitivity of the new 10×3
detection approach uncovered a number of interesting insights.
First, the data show a large variation in the amount of
transcripts in different cells at the onset of infection. These
variations likely reflect differences in the transcriptional activ-
ities of different rotavirus particles.[25] Furthermore, the tran-
scripts do not seem to accumulate in a particular cellular
compartment or in virus-induced organelles during early
infection. These results thus show that the new 10×3 probe
design is a significant step forward because it provides new
biological insights.
Conclusions
We show here that by decreasing the number of probes and
increasing the number of fluorophores on oligonucleotide
probes using click chemistry provides fluorescent probe strands
that allow efficient detection of RNA transcripts in live cells. The
probes have a superb sensitivity and allow detection of tran-
scripts that due to high secondary structure content provide
only a limited number of binding sites. Self-quenching seems to
play only a minor role, possibly because we used fluorophores
that carry two negative charges each. The new probe design is
so sensitive that it even allows flow RNA-FISH to be established
for demanding flow cytometry applications. These results pave
the way for the detection of small highly structure RNA
transcripts and transcripts with low abundance. A potential
application could be the monitoring of leukemia therapy by
flow-FISH to prevent dangerous relapse cases or the very early
detection of virus infections now needed for the detection of
the Corona virus to reduce the diagnostic gap and prevent
uncontrolled propagation of the disease.
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Eternion Red 645    Quasar 670 
  
Probe design and sequences for eGFP mRNA 
 
Figure S1. Sequence of the eGFP transcript in grey, together with the sequence of the antisense 10x3 probes in 




Into each of the DNA strands, three C8-alkyne-dU building blocks were inserted at former dT positions using 
phosphoramidites developed before[1]. 
Table S1. Sequences of the 10 oligonucleotide RNA FISH probes and the positions of the C8-alkyne-dU 
building blocks. The Oligonucleotides listed below were generated for eGFP mRNA using the Stellaris RNA FISH 
probe designer (https://www.biosearchtech.com/stellaris-designer). The positions of the modifications are 
highlighted in blue. 
 
Number Sequence 5’-> 3’ 
1 TGA ACA GCT CCT CGC CCT TGC T 
2 TGT GGC CGT TTA CGT CGC CGT C 
3 TGC CGG TGG TGC AGA TGA ACT T 
4 TCG GGC ATG GCG GAC TTG AAG A 
5 TCT TGT AGT TGC CGT CGT CCT T 
6 TGT CGC CCT CGA ACT TCA CCT C 
7 TGT TGC CGT CCT CCT TGA AGT C 
8 TGC ACG CTG CCG TCC TCG ATG T 
9 TCA GGT AGT GGT TGT CGG GCA G 
10 TGT ACA GCT CGT CCA TGC CGA G 
 
Click reaction 
Each probe was prepared separately. The Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC) was performed 
combining 5 nmole of DNA oligo and 45 nmol dye azide: TAMRA-azide (baseclick GmbH) or Eterneon Red 647-
azide (baseclick GmbH) in 20 µL reaction volume in the presence of the catalyst CuBr 6.25 mM, tris-
hydroxypropyltriazolylmethylamine (THPTA) 12.5 mM, and 2.5 % DMSO. The solution is then incubated for 1 h at 
45 °C at 700 RPM protected from light and then cleaned by standard EtOH precipitation before the application in 
FISH experiments. Further purification was not needed. 
  
HPLC example 
For RP‐HPLC analysis of labelled probes, a Waters system (Waters e2695 Separation Modul and Waters 2998 
PDA) equipped with the XBridgeTM OST C18 column (2.5 µm, 4.6 mm x 50 mm) was used. Linear gradients of 
buffer A (0.1 M triethylammonium acetate, pH 7.5) to buffer B (0.1 M triethylammonium acetate in 80 % acetonitrile, 
pH 7.5) were run at a flow rate of 1.5 mL/min at 40 °C column temperature. For detection of oligonucleotide mixtures 
260 nm absorbance was chosen. 
Method: 
Buffer A: 100 % to 70 % in 8 min, 70 % to 15 % in 2 min, 15 % to 0 % in 1 min. 
Buffer B: 0 % to 30 % in 8 min, 30 % to 85 % in 2 min, 85 % to 100 % in 1 min 
HPL chromatogram example of the oligo before (i) and after click reaction (ii) 
 









Comparison of commercial set of probes and click probes 
Analytical RP-HPLC was performed using a Macherey-Nagel Nucleodur 100-3 C18ec column on a Waters Alliance 
2695 Separation Module coupled with a 2996 Photodiode Array Detector and a 2475 Multi wavelength 
Fluorescence Detector, using a flow of 0.5 mL/min. Linear gradients of buffer A (0.1 M triethylammonium acetate, 
pH 7.0) to buffer B (0.1 M triethylammonium acetate in 80 % acetonitrile, pH 7.0) were run at a flow rate of 0.5 
mL/min. For detection of oligonucleotide mixture 260 nm absorbance was chosen, while 647 nm absorbance was 
used to detect the fluorophore. Method: 0-60 % B in 20 min, 60 to 100 % B in 1 min, 100 % B for 4 min  
Table S2. Sequence of the commercial FISH probes, consisting of 30 oligonucleotides with one dye each (30x1) 
 
Number Sequence 5’-> 3’ 
1 GCT CCT CGC CCT TGC TCA CCA T 
2 ATG GGC ACC ACC CCG GTG AAC A 
3 GTC GCC GTC CAG CTC GAC CAG G 
4 CGC TGA ACT TGT GGC CGT TTA C 
5 TCG CCC TCG CCC TCG CCG GAC A 
6 GGT CAG CTT GCC GTA GGT GGC A 
7 CGG TGG TGC AGA TGA ACT TCA G 
8 GGC CAG GGC ACG GGC AGC TTG C 
9 GGT CAG GGT GGT CAC GAG GGT G 
10 GGC TGA AGC ACT GCA CGC CGT A 
11 TGC TTC ATG TGG TCG GGG TAG C 
12 GGC GGA CTT GAA GAA GTC GTG C 
13 CCT GGA CGT AGC CTT CGG GCA T 
14 TCC TTG AAG AAG ATG GTG CGC T 
15 GCG GGT CTT GTA GTT GCC GTC G 
16 TCG ATG CGG TTC ACC AGG GTG T 
17 CCT TGA AGT CGA TGC CCT TCA G 
18 TGC CCC AGG ATG TTG CCG TCC T 
19 GTT GTA GTT GTA CTC CAG CTT G 
20 GCC ATG ATA TAG ACG TTG TGG C 
21 GAT GCC GTT CTT CTG CTT GTC G 
22 GGC GGA TCT TGA AGT TCA CCT T 
23 ACG CTG CCG TCC TCG ATG TTG T 
24 GCT GGT AGT GGT CGG CGA GCT G 
25 CCG TCG CCG ATG GGG GTG TTC T 
26 GGT TGT CGG GCA GCA GCA CGG G 
27 GCG GAC TGG GTG CTC AGG TAG T 
28 CTC GTT GGG GTC TTT GCT CAG G 
29 GCA GGA CCA TGT GAT CGC GCT T 








Figure S3. Comparison of (a) a commercial probe set (30x1 Quasar 670 dye) and (b) a clicked probe set (10x3 
Eterneon-Red dye). Both sets were loaded in equal amounts, based on 260 nm absorption. Both dyes are very 
similar cyanine-5 fluorophores. 
 
 
Figure S4. Fluorescence analysis: The fluorescence analysis of the two sets of probes confirm what described 
previously following the absorbance at 647 nm. Using the same amount of DNA, the commercial probes (a) show 
an overall lower fluorescence value than the click probes (b). Detection parameters: λexc: 647 nm, λem: 665 nm. 
 
  
In-vitro-FISH with total RNA from eGFP- HEK293T cell line 
Total RNA was extracted from eGFP-HEK239T cells using Total-RNA-kit, peqGOLD, catalogue number 732-2868 
(VWR). FISH in total RNA was performed as reported in Semrau et. al. with minor changes. After DNase digestion, 
0.5 µl of total RNA was spotted in the center of an RNase-free cover slips, which was attached to a microscope 
slide. The total RNA spotted on cover slips were dried for 20 min at 80 °C. After fixation of the spots for 5 min at 
RT, a washing step with 2x saline sodium citrate (SSC) followed. Either the commercial (30x1, labelled with Quasar 
670) or the CuAAC-labelled probes (10x3, Eterneon-Red 647 azide) were added to the spotted RNA in hybridization 
buffer (300 mM NaCl, 30 mM trisodium citrate, pH 7.0 in nuclease-free water, 10 % (v/v) formamide) and incubated 
for 5 min at 80 °C. The hybridization buffer including the FISH probes was washed with washing buffer (300 mM 
NaCl, 30 mM trisodium citrate, pH 7.0, 10 % (v/v) formamide in RNase-free water). The samples were imaged in 
presence of 2xSSC.  
 
 
Figure S5. In vitro FISH experiment of total RNA extracted from eGFP-HEK239T cells. Total RNA from eGFP-
HEK239T cells hybridized with the CuAAC-labelled probes (10x3) showed a very high signal of diffraction limited 
spots. In the control experiment, total RNA from eGFP-HEK239T cells was hybridized with the commercial probe 
set (30x1). Only a very week specific signal was detected. Scale bars: 50 µm 
 
Titration for different numbers of triple labelled oligonucleotides 
Since the oligonucleotides were labelled separately via click chemistry, a setting of different numbers of 
oligonucleotides to a probe set was possible. Four probe sets were prepared: 3x3, 5x3, 7x3 and 10x3 with 10 ng 
total amount of the oligonucleotides in each set. The sets were hybridized with fixed and permeabilized eGFP-
HEK293T and with HEK293T for the negative control without eGFP expression. 
 
 
Figure S6. Differences in the signal intensities of eGFP-mRNA using different numbers of triple labelled probes 
(3x3, 5x3, 7x3 and 10x3) in eGFP-expressing HEK293T cells. Scale bar: 50 µm 
  
Click post hybridization 
eGFP-HEK293T were grown in 8 chamber µ-slides cell culture plates (ibidi) until 80 % cell density is reached. After 
removing the culture medium, cells were washed with 1x RNase-free phosphate saline buffer (PBS) and fixed 15 
minutes at RT with the fixation buffer (4 % paraformaldehyde (v/v) in nuclease-free PBS. Cells were then washed 
twice with 3 % bovine serum albumin (BSA) in 1x PBS and permeabilized with 100 % EtOH for at least 1 h at 4 °C. 
After permeabilization and removing of the EtOH, cells were washed twice with 3 % BSA in 1x PBS. 5 pmol of each 
oligonucleotide in 150 µL hybridization buffer (300 mM NaCl, 30 mM trisodium citrate, pH 7.0 in nuclease-free water, 
10 % (v/v) formamide) was added to each chamber. The hybridization occurred for 3 h at 37 °C. The unbound 
oligonucleotides and the hybridization buffer were washed using 10 % washing buffer (300 mM NaCl, 30 mM 
trisodium citrate, pH 7.0, 10 % (v/v) formamide in RNase-free water) followed by two washing steps with 3 % BSA 
in 1x PBS. 250 µL of click cocktail (CuSO4 50 µM, THPTA 250 µM, 7 equivalents 5-TAMRA-PEG3-azide to a final 
concentration of 25 µM and NaAscorbate to final concentration of 2.5 mM) was added to the cells, which were then 
incubated 30 minutes at RT protected from light. After hybridization, cells were washed three times either with 3 % 
BSA (w/v) or DMSO (5, 10, 20, 30, 40 and 50 % in 1x PBS (v/v)). Afterwards, 2x SSC was added to the cells and 
analysis via microscopy was performed. The signal to noise ratio is reduced when the concentration of DMSO is 
increased. Scale bar: 50 µm. 
 
Figure S7. Click reaction of the FISH probes after hybridization.  
  
Cell culture of human cell strains  
HEK293T and HEK293T-eGFP cells were cultivated at 37 °C with CO2-enriched (5 %) atmosphere. Dulbecco's 
modified Eagle medium (DMEM) supplemented with 10 % fetal bovine serum (FBS), 1 % penicillin and 
streptomycin, was used as growing medium. When reaching a confluence of 70 % to 80 %, the cells were passaged 
in a new culture flask. For staining experiments, 1.5x104 cells were seeded in each well of a µ-Slide 8 Well from 
ibidi (ibiTreat, #1.5 polymer coverslip, catalog No. 80826) and cultured for two days or until a density of 80 % is 
reached. 
FISH protocol for HEK293T cells 
HEK293T cells were fixed with 4 % (v/v) paraformaldehyde in nuclease-free phosphate saline buffer (PBS) for 10 
min at room temperature. Samples were then washed twice with PBS, and the fixed cells were permeabilized with 
70 % (v/v) ethanol (200 proof) in RNAse-free water and stored in ethanol at +4 °C for at least 12 hours prior to 
hybridization. Permeabilized cells were then re-hydrated for 5 min in a pre-hybridization buffer (300 mM NaCl, 30 
mM trisodium citrate, pH 7.0 in nuclease-free water, 10 % v/v formamide, supplemented with 2 mM vanadyl 
ribonucleoside complex). Re-hydrated samples were hybridized with an equimolar mixture of 10 RNA FISH DNA 
probes specific to bovine rotavirus strain RF gene segment 7 (62.5 nM final concentration, see Table S4) in a total 
volume of 200 µl of the hybridization buffer (Stellaris RNA FISH hybridization buffer, SMF-HB1-10, Biosearch 
Technologies, supplemented with 10 % v/v deionized formamide). After 4 hours of incubation at 37 °C in a 
humidified chamber, samples were briefly rinsed with the wash buffer (300 mM NaCl, 30 mM trisodium citrate, pH 
7.0, 10 % v/v formamide in nuclease-free water) after which a fresh aliquot of 300 µl of the wash buffer was applied 
to each well and incubated twice at 37 °C for 30 min. After washes, nuclei were briefly stained with 300 nM 4’,6-
diamidino-2-phenylindole (DAPI) solution in 300 mM NaCl, 30 mM trisodium citrate, pH 7.0) and the samples were 



















FISH experiments for flow cytometry analysis were performed as described previously by Arrigucci et al[2]. 
Table S3. Sequences of the BCR and ABL FISH probes labelled with click chemistry.  The sequences were 
generated using the Stellaris RNA FISH probe designer (https://www.biosearchtech.com/stellaris-designer). The 
positions of the C8-Alkyne-dU building blocks are highlighted with blue 
Number Sequence 5’-> 3’ 
BCR#1 TAG CTC TTC TTT TCC TTG GC 
BCR#2 ATC CGC TCG AAG TTG GAC CT 
BCR#3 AAC TCG ACG TTC ACG TAG AA 
BCR#4 TTT TTG CGC TCC ATC TGC AT 
BCR#5 TTC AAC TCG GCG TCC TCG TA 
BCR#6 ATG CTC TGG TAG GGC TGG TA 
BCR#7 TCC GCA ATC CTC AAA ACT CC 
BCR#8 TTC TCA TTG GAG CTG CAG TC 
BCR#9 TTG TCC CGG AAC ATG CGG TA 
BCR#10 ATC TGC GTC TCC ATG GAA GG 
BCR#11 ACT CGC TNT AGT GGA CTC CA 
BCR#12 ATC TGC TGA CTC GTC AGC AC 
BCR#13 TTG TGG ATC TCG TAG AGC TC 
BCR#14 TCA GGT TCT CGG AGA TTT CT 
BCR#15 TGG CAT CTT TGT TGC TTC TG 
  
ABL1#1 GCC ATT TTT GGT TTG GGC TT 
ABL1#2 TTG ACT GGC GTG ATG TAG TT 
ABL1#3 GTA ATG GTA CAC CCT CCC TT 
ABL1#4 ATG ATG ATG AAC CAA CTC GG 
ABL1#5 ATA ATG GAG CGT GGT GAT GA 
ABL1#6 ATA GAC AGT GGG CTT GTT GC 
ABL1#7 ATC TCC CAC TT GTCG TAG TT 
ABL1#8 TTG TGC TTC ATG GTG ATG TC 
ABL1#9 TCC TCC TTC AAG GTC TTC AC 
ABL1#10 CTT TCA TGA CTG CAG CTT CT 
ABL1#11 AGG TTC CCG TAG GTC ATG AA 
ABL1#12 ATC TGA GTG GCC ATG TAC AG 
ABL1#13 TAC CTT CAC CAA GTG GTT CT 
ABL1#14 ATT TGA TGG GGA ACT TGG CT 
ABL1#15 ATG GAG AAC TTG TTG TAG GC 
 
Cells flow cytometer data were obtained using the BD FACS Canto II equipped with air cooled green (488 nm solid 
state; 20 mW laser output) and red (633 nm HeNe; 17 W output) lasers, and the data were analyzed with the FCS 
Express 6 (De Novo Software). The fluorescent detectors/filters relevant for this study were FITC (530 +/- 30 nm) 
and APC (660 +/- 30 nm), respectively. Acquisition was done with a flow rate of 10 µL/min. FSC and SSC were 
used for detection of forward light scatter parameter and side light scatter parameter. The machine was cleaned 
before and after each measurement. The photomultiplier tube (PMT) voltage for each parameter was adjusted in 
order to have the cells displayed in the centre of the investigating plot.  
After hybridization and wash, HEK293T or HEK293T-eGFP were immediately analysed by flow cytometer, the 
samples were maintained in buffer during acquisition. 
 
Figure S8. FACS Dot plot comparison of 30x1 and 10x3 probes. (i) The negative control of the experiment, 
where FISH was performed replacing the set of probes with the same volume of H2O. A population of HEK293T 
and HEK293TeGFP was mixed in a ratio 20:1, and analyzed by FACS. The eGFP dot-plot reports the correct 
separation of the HEK293T and HEK293-eGFP. The Eterneon Red dot plot shows a mix of the two populations, 
as expected. (ii) Same result as the 10x3 probes was obtained with the 30x1 probes set by increasing the 
















Eterneon Red / Quasar 670
Eterneon Red / Quasar 670
Cells and viruses 
The rhesus monkey epithelial cell line MA104 stably expressing NSP5-EGFP [3] was cultured in DMEM (Dulbecco's 
modified Eagle medium, GlutaMax-I, 4.5 g/L glucose, ThermoFisher), supplemented with 10 % fetal bovine serum 
(FBS), 1x MEM non-essential amino acids solution (Sigma), 1 mM sodium pyruvate (Sigma) and 500 µg/ml G418 
(Roche). 
Bovine rotavirus A strain RF (G6P6[1]) was a generous gift from Dr. Ulrich Desselberger (University of Cambridge, 
UK). It was grown in MA104 Clone 1 cell line (ATCC CRL-2378.1), as described previously [4].  
For RNA imaging experiments, MA104 cells expressing NSP5-EGFP were seeded into Ibidi 8-well µ-slides and 
allowed to reach 90 % confluency prior to the infection. Confluent MA104 cell monolayers were rinsed twice with 
DMEM medium without FBS for 10 minutes to remove any residual FBS, and were subsequently infected with 
trypsin-activated bovine rotavirus at multiplicity of infection, MOI = 20.  
Rotavirus RNA imaging using RNA FISH 
Rotavirus-infected and mock-infected MA104 controls were fixed with 4 % (v/v) paraformaldehyde in nuclease-free 
phosphate saline buffer (PBS) for 10 min at room temperature. Samples were then washed twice with PBS, and 
the fixed cells were permeabilized with 70 % (v/v) ethanol (200 proof) in RNAse-free water and stored in ethanol at 
+4 °C for at least 12 hours prior to hybridization. Permeabilized cells were then re-hydrated for 5 min in a pre-
hybridization buffer (300 mM NaCl, 30 mM trisodium citrate, pH 7.0 in nuclease-free water, 10 % v/v formamide, 
supplemented with 2 mM vanadyl ribonucleoside complex). Re-hydrated samples were hybridized with an 
equimolar mixture of 10 RNA FISH DNA probes specific to bovine rotavirus strain RF gene segment 7 (62.5 nM 
final concentration, see SI Table 1) in a total volume of 200 µl of the hybridization buffer (Stellaris RNA FISH 
hybridization buffer, SMF-HB1-10, Biosearch Technologies, supplemented with 10 % v/v deionized formamide). 
After 4 hours of incubation at 37 °C in a humidified chamber, samples were briefly rinsed with the wash buffer (300 
mM NaCl, 30 mM trisodium citrate, pH 7.0, 10 % v/v formamide in nuclease-free water, after which a fresh aliquot 
of 300 µl of the wash buffer was applied to each well and incubated twice at 37 °C for 30 min. After washes, nuclei 
were briefly stained with 300 nM 4’,6-diamidino-2-phenylindole (DAPI) solution in 300 mM NaCl, 30 mM trisodium 
citrate, pH 7.0) and the samples were finally rinsed with and stored in the same buffer without DAPI prior to imaging. 
Fluorescent microscopy imaging 
HEK cells were imaged on a Zeiss Cell Observer SD microscope equipped with a Yokogawa spinning disk unit 
CSU-X1 using a 1.40 NA 100x Plan-apochromat oil immersion objective (Zeiss). RNA FISH probes were imaged 
using 532/561 nm and a BP 690 filter, and eGFP signal was imaged with 488 nm laser excitation and a BP 525/50 
filter, respectively. DAPI staining was visualized with 405 nm excitation using a BP 525/50 filter. Data analysis 
yielding the labeling efficiency was performed using ImageJ. 
Rotavirus RNA FISH probes imaging was carried out using a Nikon Ti-E widefield microscope equipped with a 100x 
1.40 NA Plan Apochromat oil immersion objective, a CoolLED pE 4000 light source, a Zyla camera and a Quad 
DAPI/FITC/CY3/CY5 HC filter set.  
Z-series spanning the full cell volume with a step size of 0.5 μm at 30 % power with 55 ms exposure times at 385 
nm for DAPI, 58 % power with 500-ms exposure times at 470 nm for eGFP and at 35 % power with 500-ms 
exposures at 550-nm for TAMRA were acquired and the final images represent maximum intensity projections 
calculated using ImageJ. 
 
  
Table S4. Into each of the DNA strands designed, three C8-alkyne-dU building blocks were inserted at former dT 
positions using phosphoramidites developed before[1]. Sequences of the 10 oligonucleotide RNA FISH probes 
listed below were generated for the rotavirus A gene segment 7 (gene accession no. KF729693.1) using the Stellaris 
RNA FISH probe designer (https://www.biosearchtech.com/stellaris-designer). The position of the modifications is 
highlighted in blue. 
Number Sequence 5’ -> 3’ 
1 ATT GTG GTA TAT TCA ATA CCA 
2 AGT CCA TTA TTC TCG TTA TTG 
3 GTT TTG CGC ATT TAT TAT GGT 
4 AAG GTA TCT TTC CAT TCA GTA 
5 GTT CTT GTG TAG AGT CAT ATT 
6 ATA GCG TTA TGT CCA TTG GAT 
7 ACC AAG TGT TTG TGT ATT TAA 
8 TGT AAT CAC TAA CTT CTC CGT 
9 CTG TAT GAC TGC TAC GTT CTC 
10 GTG GTG TAG TTG TTG GAT CAG 
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6HB: 6-helix bundle 
α-Gal A: α-Galactosidase A  
A: Adenine 
AGEs: advanced glycation end products  
AFM: Atomic force microscopy 
AGE: Agarose gel electrophoresis 
BTTAA: 2-(4-((bis((1-(tert-butyl)-1H-1,2,3-triazol-4-yl)methyl)amino)methyl)-1H-1,2,3-triazol-1-yl)acetic acid  
BTTES: tris(triazolylmethyl)amine 
C: Cytosine 
CM: chainmails  
CPG: controlled pore glass 
CuAAC: Cupper(I) Catalyzed Azide-Alkine Cycle addition 
DMT: 4,4′-dimethoxytrityl 
DNA: The deoxyribonucleic acid  
DNase I: deoxyribonuclease I 
DNS: DNA structures 
dsDNA: double stranded DNA filament  
EdU: 5-Ethynil-deoxy-Uridine 
EGFP: Enhanced green fluorescent protein 
FACS: fluorescent activated cell sorting  
FBS: fetal bovine serum  
FISH: Fluorescent In Situ Hybridization 
G: Guanine  
GOs: Gene oligonucleotides 
ITN: Innovative Training Network 




LAMP-1: Lysosomal-associated membrane protein 
LMU: Ludwig Maximilians Universität  
LNP: Lipid Nanoparticle 
mRNA: messenger RNA 




PAGE: Polyacrylamide gel electrophoresis 
PCA: DNA polymerase cycling assembly  
PCR: Polymerase chain reaction 
PABP: poly(A) binding protein 
RO: rectangular DNA origami 
SBO: Square box DNA origami  
siRNA: Short interfering RNA 
SR-A: scavenger receptors of class A  
SR-B: scavenger receptors of class B 
SR-E: scavenger receptors of class E 
SPAAC: Strain promoted azide alkyne cycloaddition 
ssDNA: single strand DNA filament  
T: Thymine  
TdT: terminal deoxynucleotidyl transferase  
TEM: transmission electron microscopy  
TD: tetrahedral  
tRNA: transfer RNA  
THPTA: Tris((1-hydroxy-propyl-1H-1,2,3-triazol-4-yl)methyl)amine  




U: Uracil  
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